FedInvent™ Patents

Patent Details for Tuesday, December 19, 2017 

This page was updated on Monday, March 27, 2023 at 05:22 AM GMT

Department of Health and Human Services (HHS) 

US 09844214 Ghatnekar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) MUSC Foundation for Research Development (Charleston, South Carolina)
ASSIGNEE(S) MUSC Foundation for Research Development (Charleston, South Carolina)
INVENTOR(S) Gautam Ghatnekar (Charleston, South Carolina);  Robert Gourdie (Charleston, South Carolina);  Jane Jourdan (Charleston, South Carolina)
ABSTRACT The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
FILED Tuesday, June 28, 2016
APPL NO 15/195569
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0226 (20130101) Original (OR) Class

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/177 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844320 Schallek
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Jesse Schallek (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Jesse Schallek (Rochester, New York)
ABSTRACT A method for creating a virtual 2D image of an object moving in a blood vessel includes the steps of: providing an imaging apparatus capable of acquiring 1D images. The imaging apparatus is communicatively coupled to a computer. Multiple 1D images of a substantially fixed footprint on a surface of an organ are acquired over a period of time. A virtual 2D image showing the object moving in the blood vessel is formed by combining by computer the multiple 1D images. The virtual 2D image can be displayed and/or saved to a non-volatile memory. A system to perform the method is also described. Another method for creating a virtual 1D image of an object moving in a blood vessel is also described.
FILED Thursday, January 22, 2015
APPL NO 14/602480
ART UNIT 2872 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/14 (20130101)
A61B 3/102 (20130101)
A61B 3/1241 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844483 Barlow et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Steven M. Barlow (Lawrence, Kansas);  Douglas S. Kieweg (Lawrence, Kansas);  Emily Zimmerman (Demver, Colorado)
ASSIGNEE(S) The University of Kansas (Lawrence, Kansas)
INVENTOR(S) Steven M. Barlow (Lawrence, Kansas);  Douglas S. Kieweg (Lawrence, Kansas);  Emily Zimmerman (Demver, Colorado)
ABSTRACT A method for providing vestibular stimulation includes: providing an infant in a vestibular stimulation device; associating sensors to the infant; moving the vestibular stimulation device to provide vestibular stimulation treatment; and obtaining sensor data during the treatment. The vestibular stimulation device includes a holder member; a platform; a mechanical system coupling the holder member to the platform; sensors configured to detect one or more parameters of the infant; and a computing system having a user input and/or output interface operably coupled to the mechanical system and the sensors to provide mechanical data to the mechanical system in order to control movement of the holder member relative to the platform and to collect the one or more parameters of the living subject from the sensors.
FILED Thursday, April 19, 2012
APPL NO 14/112509
ART UNIT 3771 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/024 (20130101)
A61B 5/0816 (20130101)
A61B 5/1135 (20130101)
A61B 5/1455 (20130101)

Transport, Personal Conveyances, or Accommodation Specially Adapted for Patients or Disabled Persons; Operating Tables or Chairs; Chairs for Dentistry; Funeral Devices
A61G 5/101 (20130101)

Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 1/001 (20130101) Original (OR) Class
A61H 1/005 (20130101)
A61H 2201/0142 (20130101)
A61H 2201/0149 (20130101)
A61H 2201/0173 (20130101)
A61H 2201/501 (20130101)
A61H 2201/1666 (20130101)
A61H 2201/5038 (20130101)
A61H 2201/5064 (20130101)
A61H 2201/5084 (20130101)
A61H 2201/5097 (20130101)
A61H 2230/065 (20130101)
A61H 2230/208 (20130101)
A61H 2230/425 (20130101)
A61H 2230/625 (20130101)

Containers Specially Adapted for Medical or Pharmaceutical Purposes; Devices or Methods Specially Adapted for Bringing Pharmaceutical Products into Particular Physical or Administering Forms; Devices for Administering Food or Medicines Orally; Baby Comforters; Devices for Receiving Spittle
A61J 17/001 (20150501)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 21/00 (20130101)
A61M 2021/0022 (20130101)
A61M 2230/42 (20130101)
A61M 2230/62 (20130101)
A61M 2230/63 (20130101)
A61M 2230/205 (20130101)
A61M 2240/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844514 Williams et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (Louisville, Kentucky)
ASSIGNEE(S) University of Louisville Research Foundation, Inc. (Louisville, Kentucky)
INVENTOR(S) Stuart K. Williams (Harrods Creek, Kentucky);  James B. Hoying (Louisville, Kentucky);  Amanda J. LeBlanc (Louisville, Kentucky)
ABSTRACT This application discloses methods for treating an established myocardial infarction, including treatment with an epicardial construct containing stromal vascular fraction (SVF) from adipose tissue which may be seeded onto a biocompatible substrate, which preserves microvascular function and LV contractile mechanisms.
FILED Wednesday, July 09, 2014
APPL NO 14/327497
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/70 (20130101) Original (OR) Class
A61K 35/35 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844528 Dalton et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Tennessee Research Foundation (Knoxville, Tennessee)
ASSIGNEE(S) UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, Tennessee)
INVENTOR(S) James T. Dalton (Ann Arbor, Michigan);  Thamarai Ponnusamy (Memphis, Tennessee);  Ramesh Narayanan (Cordova, Tennessee)
ABSTRACT This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy.
FILED Thursday, June 23, 2016
APPL NO 15/190732
ART UNIT 1672 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/277 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844534 Faller et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Faller and Williams Technology, LLC (Fort Collins, Colorado)
ASSIGNEE(S) Faller and Williams Technology, LLC (Fort Collins, Colorado)
INVENTOR(S) Douglas V. Faller (Weston, Massachusetts);  Robert M. Williams (Fort Collins, Colorado)
ABSTRACT The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS. 11 and 12.
FILED Monday, February 06, 2017
APPL NO 15/425381
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 31/403 (20130101) Original (OR) Class
A61K 31/404 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 209/86 (20130101)
C07D 405/06 (20130101)
C07D 487/14 (20130101)

Enzymes
C12Y 207/10002 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5011 (20130101)
G01N 2333/91205 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844535 Zhang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana);  Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
INVENTOR(S) Zhong-Yin Zhang (Carmel, Indiana);  Maria Kontaridis (Auburndale, Massachusetts);  Li-Fan Zeng (Indianapolis, Indiana);  Jianxun Wang (Cambridge, Massachusetts)
ABSTRACT Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
FILED Wednesday, July 02, 2014
APPL NO 14/902485
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/404 (20130101) Original (OR) Class
A61K 31/427 (20130101)
A61K 31/428 (20130101)
A61K 31/433 (20130101)
A61K 31/4025 (20130101)
A61K 31/4178 (20130101)
A61K 31/4184 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844542 Emmitte et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Kyle A. Emmitte (Spring Hill, Tennessee);  Craig W. Lindsley (Brentwood, Tennessee);  P. Jeffrey Conn (Nashville, Tennessee);  Andrew S. Felts (Brentwood, Tennessee);  Alice L. Rodriguez (Nashville, Tennessee);  Katrina A. Smith (Murfreesboro, Tennessee);  Carrie K. Jones (Nashville, Tennessee)
ABSTRACT Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
FILED Tuesday, November 18, 2014
APPL NO 15/037320
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/444 (20130101) Original (OR) Class
A61K 31/506 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 471/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844548 Gonda et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) ARADIGM CORPORATION (Hayward, California)
ASSIGNEE(S) ARADIGM CORPORATION (Hayward, California)
INVENTOR(S) Igor Gonda (San Francisco, California);  James Blanchard (El Granada, California);  David C. Cipolla (San Ramon, California)
ABSTRACT Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
FILED Monday, November 28, 2016
APPL NO 15/362405
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/12 (20130101)
A61K 9/0073 (20130101)
A61K 9/0078 (20130101)
A61K 9/127 (20130101)
A61K 31/496 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844561 Imai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) Washington University (Saint Louis, Missouri)
ASSIGNEE(S) Washington University (Saint Louis, Missouri)
INVENTOR(S) Shin-ichiro Imai (Saint Louis, Missouri);  Rajendra Apte (Clayton, Missouri)
ABSTRACT Disclosed are methods and compositions related to methods of treating, ameliorating, mitigating, slowing, arresting, preventing or reversing various diseases and conditions, including age-related obesity, age-related increases in blood lipid levels, age-related decreases in insulin sensitivity, age-related decreases in memory function, and age-related changes in eye function such as macular degeneration. The methods comprise administering nicotinamide mononucleotide (NMN) to a subject. In some embodiments, the administration can be oral administration. Also disclosed are pharmaceutical compositions comprising NMN.
FILED Tuesday, September 15, 2015
APPL NO 14/855293
ART UNIT 1673 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 9/0048 (20130101)
A61K 9/0053 (20130101)
A61K 31/455 (20130101)
A61K 31/706 (20130101) Original (OR) Class
A61K 31/7064 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844562 Mirkin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
NIH Office of the Director (NIHOD)
APPLICANT(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
ASSIGNEE(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
INVENTOR(S) Chad A. Mirkin (Wilmette, Illinois);  David A. Giljohann (Chicago, Illinois);  Dwight S. Seferos (Toronto, Canada);  Andrew E. Prigodich (Evanston, Illinois);  Pinal C. Patel (Chicago, Illinois)
ABSTRACT The present invention concerns nanoparticles functionalized with duplex RNA for a variety of uses, including but not limited to gene regulation. More specifically, the disclosure provides a new strategy for conjugating RNA to a nanoparticle to achieve increased stability and activity.
FILED Wednesday, August 26, 2015
APPL NO 14/836528
ART UNIT 1674 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101) Original (OR) Class
A61K 47/6923 (20170801)
A61K 48/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/111 (20130101)
C12N 15/1137 (20130101)
C12N 2310/14 (20130101)
C12N 2310/351 (20130101)
C12N 2310/531 (20130101)
C12N 2320/32 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844563 Zager et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) FRED HUTCHINSON CANCER RESEARCH CENTER (Seattle, Washington)
ASSIGNEE(S) FRED HUTCHINSON CANCER RESEARCH CENTER (Seattle, Washington)
INVENTOR(S) Richard A. Zager (Mercer Island, Washington);  Ali C M Johnson (Mill Creek, Washington)
ABSTRACT The present disclosure provides compositions, kits, and methods to protect organs by inducing acquired cytoresistance without causing injury to the organ. The compositions, kits, and methods utilize heme proteins, iron and/or vitamin B12 and, optionally, agents that impact heme protein metabolism.
FILED Friday, January 06, 2017
APPL NO 15/400690
ART UNIT 1619 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0226 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/194 (20130101)
A61K 31/555 (20130101)
A61K 31/714 (20130101) Original (OR) Class
A61K 33/26 (20130101)
A61K 38/42 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 23/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844564 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Industrial Cooperation Foundation Chonbuk National University (Jeollabuk-do, South Korea);  Beth Israel Deaconess Medical Center (Boston, Massachusetts)
ASSIGNEE(S) Industrial Cooperation Foundation Chonbuk University (Jeonbuk, South Korea);  Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts)
INVENTOR(S) Dong Won Lee (Jeollabuk-do, South Korea);  Dong Hyun Hong (Gyeonggi-do, South Korea);  Peter M. Kang (Lexington, Massachusetts)
ABSTRACT The present invention includes a vanillyl alcohol-containing copolyoxalate copolymer (PVAX). The present invention also includes a PVAX microparticle comprising PVAX. In one aspect, the compositions of the invention can be used as a drug delivery system, an antioxidant or anti-inflammatory composition, a composition for preventing or treating ischemic disease, a composition for inhibiting the side effects of anticancer drugs, a contrast agent, and/or a composition for diagnosing ischemic disease.
FILED Monday, September 30, 2013
APPL NO 14/432114
ART UNIT 1611 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/14 (20130101)
A61K 31/765 (20130101) Original (OR) Class
A61K 49/0093 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 63/133 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844569 Gros et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United State of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) The United State of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Alena Gros (Washington, District of Columbia);  Steven A. Rosenberg (Potomac, Maryland)
ABSTRACT Methods of obtaining a cell population enriched for tumor-reactive T cells, the method comprising: (a) obtaining a bulk population of peripheral blood mononuclear cells (PBMCs) from a sample of peripheral blood; (b) specifically selecting CD8+T cells that also express PD-1 and/or TIM-3 from the bulk population; and (c) separating the cells selected in (b) from unselected cells to obtain a cell population enriched for tumor-reactive T cells are disclosed. Related methods of administering a cell population enriched for tumor-reactive T cells to a mammal, methods of obtaining a pharmaceutical composition comprising a cell population enriched for tumor-reactive T cells, and isolated or purified cell populations are also disclosed.
FILED Tuesday, April 30, 2013
APPL NO 14/771593
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5005 (20130101)
G01N 33/5094 (20130101)
G01N 33/56972 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844582 Wittrup et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Karl Dane Wittrup (Chestnut Hill, Massachusetts);  Byron Hua Kwan (Boston, Massachusetts);  Shuning Gai (Cambridge, Massachusetts)
ABSTRACT The present invention relates to methods of treating cancer with a combination of extended-PK IL-2 and one or more therapeutic agents, such as a therapeutic antibody. The methods of the invention are applicable across any type of cancer.
FILED Tuesday, May 21, 2013
APPL NO 14/402889
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/385 (20130101)
A61K 38/2013 (20130101) Original (OR) Class
A61K 38/2013 (20130101)
A61K 39/39533 (20130101)
A61K 45/06 (20130101)
A61K 47/48215 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844583 Chang
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
ASSIGNEE(S) Indiana University Research and Technology Corp. (Indianapolis, Indiana)
INVENTOR(S) Ching-Pin Chang (Indianapolis, Indiana)
ABSTRACT Nucleic acids encoding modified myosin heavy-chain-associated RNA transcripts are provided. The modified myosin heavy-chain-associated RNA transcripts belongs to a cluster of long noncoding RNAs (lncRNA) and bind to chromatin remodeler Brg1 to inhibit Brg1's genomic targeting and gene regulation function. The modified myosin heavy-chain-associated RNA transcripts expressed in an individual inhibit Brg1's gene regulation function and protect the heart of the individual from myopathy and failure. One of the modified heavy-chain-associated RNAs is a 400 base pair fragment segmented from a natural 779 base pair sequence of Mhrt (Mhrt779) and has the same cardioprotective effects as the Mhrt779.
FILED Friday, October 16, 2015
APPL NO 14/884827
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0275 (20130101)
A01K 2217/052 (20130101)
A01K 2217/203 (20130101)
A01K 2217/206 (20130101)
A01K 2227/105 (20130101)
A01K 2267/0375 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/43 (20130101) Original (OR) Class
A61K 48/00 (20130101)

Peptides
C07K 14/4716 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/14 (20130101)
C12N 2310/14 (20130101)

Enzymes
C12Y 306/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844585 Olbricht et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
APPLICANT(S) William L. Olbricht (Ithaca, New York);  Keith B. Neeves (Philadelphia, Pennsylvania);  Conor Foley (Ithaca, New York);  Russell T. Matthews (Skaneateles, New York);  W. Mark Saltzman (New Haven, Connecticut);  Andrew Sawyer (New Haven, Connecticut)
ASSIGNEE(S) YALE UNIVERSITY (New Haven, Connecticut);  CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) William L. Olbricht (Ithaca, New York);  Keith B. Neeves (Philadelphia, Pennsylvania);  Conor Foley (Ithaca, New York);  Russell T. Matthews (Skaneateles, New York);  W. Mark Saltzman (New Haven, Connecticut);  Andrew Sawyer (New Haven, Connecticut)
ABSTRACT An embodiment of the invention is directed to a microfabricated, silicon-based, Convection Enhanced Delivery (CED) device. The device comprises a silicon shank portion, at least one individual parylene channel disposed along at least a part of an entire length of the shank, wherein the channel has one or more dimensioned fluid exit ports disposed at one or more respective locations of the channel and a fluid (drug) input opening. The fluid input opening may be configured or adapted to be connected to a fluid reservoir and/or a pump and/or a meter and/or a valve or other suitable control device(s) or apparatus that supplies and/or delivers fluid (e.g., a drug) to the microfabricated device. The device may have multiple channels disposed side by side or in different surfaces of the device. The device may be rigid, or flexible, in which case a flexible device can be attached to a bio-degradable support scaffold that provides sufficient structural rigidity for insertion of the device into the target tissue. In certain “functionalized” embodiments of the invention, the CED device is equipped with integrated electrodes and/or a sensor (e.g., glutamate) to detect and convey selective parametric information. Another embodiment of the invention is directed to a CED method for drugs and/or other agents. The method may comprise the delivery of enzymes or other materials to modify tissue permeability and improve drug diffusion. Another embodiment of the invention is directed to a method for making a device for CED of drugs.
FILED Wednesday, June 25, 2014
APPL NO 14/314119
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/47 (20130101) Original (OR) Class

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/1408 (20130101)
A61M 37/00 (20130101)
A61M 37/0015 (20130101)
A61M 2037/003 (20130101)
A61M 2037/0023 (20130101)
A61M 2210/0693 (20130101)

Enzymes
C12Y 302/01 (20130101)
C12Y 302/01035 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844592 Blander et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Julie Magarian Blander (North Haven, Connecticut);  Leif Erik Sander (Berlin, Germany)
ASSIGNEE(S) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (New York, New York)
INVENTOR(S) Julie Magarian Blander (North Haven, Connecticut);  Leif Erik Sander (Berlin, Germany)
ABSTRACT The disclosure features vaccine adjuvants comprising prokaryotic mRNA, and methods of vaccination using the adjuvants. More specifically, the disclosure provides a vaccine composition comprising a nonviable immunogen (e.g., heat-killed bacterium), a tumor antigen, or an immunogenic peptide of microbial or mammalian origin, and an adjuvant, wherein adjuvant comprises prokaryotic mRNA (e.g., bacterial mRNA), as well as the methods of using the vaccine compositions. Further disclosed are the structural features of the prokaryotic mRNA used as the adjuvants.
FILED Tuesday, July 17, 2012
APPL NO 14/233631
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/0011 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 2039/522 (20130101)
A61K 2039/585 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844605 Pak et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Pittsburgh of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) THE UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh, Pennsylvania)
INVENTOR(S) Stephen C. Pak (Pittsburgh, Pennsylvania);  David H. Perlmutter (Pittsburgh, Pennsylvania);  Gary A. Silverman (Pittsburgh, Pennsylvania)
ABSTRACT The present invention relates to methods and compositions for high content drug screening in Caenorhabditis elegans which may be used to identify compounds that treat disorders associated with protein aggregation. It is based, at least in part, on the discovery that Caenorhabditis elegans, genetically modified to create a model system for disorders of protein aggregation, could be used, in a high throughput screening system, to identify agents that reduce the amount of aggregated protein.
FILED Friday, July 18, 2014
APPL NO 14/335413
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0278 (20130101)
A01K 67/0336 (20130101)
A01K 2267/0312 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 35/00 (20130101)
A61K 49/0008 (20130101) Original (OR) Class

Peptides
C07K 14/47 (20130101)
C07K 2319/60 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6897 (20130101)
C12Q 2600/136 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5085 (20130101)
G01N 2500/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844656 Ferrara et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Katherine W. Ferrara (Davis, California);  Azedah Kheirolomoom (Sacramento, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Katherine W. Ferrara (Davis, California);  Azedah Kheirolomoom (Sacramento, California)
ABSTRACT A method for localizing delivery of an agent to a target site in a subject is provided. The method allows accumulation and/or release of the agent at the target site in the subject through the use of an energy source.
FILED Tuesday, March 01, 2011
APPL NO 13/581274
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0009 (20130101)
A61K 9/0019 (20130101)
A61K 9/107 (20130101)
A61K 9/127 (20130101)
A61K 9/1271 (20130101)
A61K 9/1273 (20130101)
A61K 9/1277 (20130101)
A61K 31/704 (20130101)
A61K 31/704 (20130101)
A61K 33/34 (20130101)
A61K 33/34 (20130101)
A61K 41/0028 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 37/0092 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844663 Swaminathan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Palo Alto, California)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Palo Alto, California)
INVENTOR(S) Aravind Swaminathan (San Mateo, California);  Ellis Garai (Palo Alto, California)
ABSTRACT A device for positioning an electrode in tissue includes: a lead body having a distal portion; an electrode array coupled to the lead distal portion; an anchoring element having an anchor tip and being operable in a first configuration in which the anchor tip is retracted within the lead and in a second configuration in which the anchor tip is extended outside the lead and configured to fixate within the tissue; and a displacement mechanism that is actuated to bias the electrode array or the anchoring element toward the tissue. A method for positioning an electrode in tissue includes: navigating, to the tissue, a lead with an electrode array, an anchoring element with a distal anchor tip, and a displacement mechanism; biasing the electrode array and anchoring element towards the tissue with the displacement mechanism; and deploying the anchoring element, and verifying fixation of the anchor tip within the tissue.
FILED Monday, May 11, 2015
APPL NO 14/708792
ART UNIT 3731 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/057 (20130101) Original (OR) Class
A61N 1/0558 (20130101)
A61N 1/0573 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845237 Tseng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Hsian-Rong Tseng (Los Angeles, California);  Hao Wang (Los Angeles, California);  Shutao Wang (Los Angeles, California);  Helen Su (Torrance, California);  Caius G. Radu (Los Angeles, California);  Johannes Czernin (Pacific Palisades, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Hsian-Rong Tseng (Los Angeles, California);  Hao Wang (Los Angeles, California);  Shutao Wang (Los Angeles, California);  Helen Su (Torrance, California);  Caius G. Radu (Los Angeles, California);  Johannes Czernin (Pacific Palisades, California)
ABSTRACT A supramolecular approach has been developed for preparation of size-controllable nanoparticles, from three different molecular building blocks.
FILED Friday, February 26, 2010
APPL NO 13/148869
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/62 (20170801)
A61K 47/6923 (20170801)
A61K 47/48238 (20130101)
A61K 47/48861 (20130101)

Nanostructures Formed by Manipulation of Individual Atoms, Molecules, or Limited Collections of Atoms or Molecules as Discrete Units; Manufacture or Treatment Thereof
B82B 3/00 (20130101) Original (OR) Class

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 83/008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845295 Cushman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
INVENTOR(S) Mark S Cushman (West Lafayette, Indiana);  Wei Lv (West Lafayette, Indiana);  Li-Ming Zhao (Xuzhou, China PRC)
ABSTRACT Triphenylethylene compounds of formula (II)
as dual aromatase inhibitors and selective estrogen receptors modulators are described. Also described are methods for treating patients of breast cancers, and patients of breast cancer comorbid with osteoporosis, using the described triphenylethylence compounds or pharmaceutical formulations thereof.
FILED Tuesday, November 22, 2016
APPL NO 15/358886
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 39/20 (20130101)
C07C 255/36 (20130101)

Heterocyclic Compounds
C07D 233/64 (20130101) Original (OR) Class
C07D 249/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845296 Ojima et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Research Foundation for The State University of New York (Albany, New York)
ASSIGNEE(S) The Research Foundation for The State University of New York (Albany, New York)
INVENTOR(S) Iwao Ojima (Port Jefferson, New York);  Divya Awasthi (Setauket, New York)
ABSTRACT The present invention relates to novel 2,5,6-benzimidazole derivatives and pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating a patient infected by Mycobacterium tuberculosis by administering to the patient a 2,5,6-benzimidazole derivative or a pharmaceutically acceptable salt thereof.
FILED Wednesday, November 19, 2014
APPL NO 15/037704
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4184 (20130101)

Heterocyclic Compounds
C07D 235/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845317 Burke et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Martin D. Burke (Champaign, Illinois);  David M. Knapp (Boonville, Indiana);  Eric P. Gillis (Wallingford, Connecticut)
ABSTRACT A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture:
R1—B-T  (I);
where R1 represents an organic group, T represents a conformationally rigid protecting group, and B represents boron having sp3 hybridization. When unprotected, the corresponding organoboronic acid is unstable by the boronic acid neat stability test. The reaction mixture further includes a base having a pKB of at least 1 and a palladium catalyst. The method further includes forming a cross-coupled product in the reaction mixture.
FILED Friday, April 29, 2016
APPL NO 15/142418
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 61/00 (20130101)

Acyclic or Carbocyclic Compounds
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 13/28 (20130101)
C07C 15/46 (20130101)
C07C 15/58 (20130101)
C07C 41/30 (20130101)
C07C 41/30 (20130101)
C07C 43/2055 (20130101)
C07C 2527/173 (20130101)
C07C 2531/12 (20130101)
C07C 2531/24 (20130101)
C07C 2601/02 (20170501)

Heterocyclic Compounds
C07D 207/34 (20130101)
C07D 207/325 (20130101)
C07D 207/333 (20130101)
C07D 209/12 (20130101)
C07D 209/30 (20130101)
C07D 213/16 (20130101)
C07D 213/50 (20130101)
C07D 213/57 (20130101)
C07D 213/73 (20130101)
C07D 241/42 (20130101)
C07D 263/56 (20130101)
C07D 307/36 (20130101)
C07D 307/42 (20130101)
C07D 307/80 (20130101)
C07D 333/16 (20130101)
C07D 401/04 (20130101)
C07D 405/04 (20130101)
C07D 405/12 (20130101)
C07D 409/04 (20130101)
C07D 413/04 (20130101) Original (OR) Class

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/55 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845327 Krainc et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Dmitri Krainc (Boston, Massachusetts);  Joseph R. Mazzulli (Boston, Massachusetts)
ASSIGNEE(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
INVENTOR(S) Dmitri Krainc (Boston, Massachusetts);  Joseph R. Mazzulli (Boston, Massachusetts)
ABSTRACT The present disclosure provides technologies relating to lysosomal activation. The disclosure provides several strategies for increasing level and/or activity of lysosomal enzyme, and furthermore demonstrates the surprising applicability of such strategies in the treatment and/or prophylaxis of certain proteinopathies. Among other things, the present invention provides methods and compositions for the treatment and/or prophylaxis of proteinopathies other than lysosomal storage diseases through lysosomal activation. In particular, the present disclosure provides methods and compositions for the treatment and/or prophylaxis of neurodegenerative proteinopathies, and in particular those associated with accumulation of α-synuclein. The present disclosure specifically provides methods and compositions for the treatment and/or prophylaxis of Parkinson's disease.
FILED Friday, June 22, 2012
APPL NO 14/127546
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 487/04 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/34 (20130101)
C12Q 1/44 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/573 (20130101)
G01N 33/5008 (20130101)
G01N 2333/924 (20130101)
G01N 2500/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845341 Waldor et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (Boston, Massachusetts)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Matthew Waldor (Newton, Massachusetts);  Xiaohui Zhou (Newton, Massachusetts);  Benjamin Gewurz (Brookline, Massachusetts)
ABSTRACT Embodiments described are immunosuppressant therapeutics and compositions comprising a Vop protein derived from Vibro parahaemolyticus; and drug delivery vehicles derived from a V. parahaemolyticus expressing a mutant VopZ protein lacking amino acid residue 38-62.
FILED Tuesday, March 11, 2014
APPL NO 14/770919
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/74 (20130101)
A61K 39/02 (20130101)

Peptides
C07K 14/28 (20130101) Original (OR) Class
C07K 2319/00 (20130101)
C07K 2319/20 (20130101)
C07K 2319/31 (20130101)
C07K 2319/40 (20130101)
C07K 2319/50 (20130101)
C07K 2319/60 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845349 Goldstein et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Jason Marc Goldstein (Decatur, Georgia);  Conrad P. Quinn (Lilburn, Georgia);  Dennis A. Bagarozzi, Jr. (Lilburn, Georgia)
ABSTRACT Provided are antibodies capable of binding to a particular epitope or specifically binding to LF or LTx and enhancing the activity of the LF or LTx relative to the LF or LTx absent the antibody binding.
FILED Thursday, April 23, 2015
APPL NO 14/694627
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 7/00 (20130101)
C07K 16/1278 (20130101) Original (OR) Class
C07K 2317/34 (20130101)
C07K 2317/75 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845350 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Zhaochun Chen (North Potomac, Maryland);  Robert H. Purcell (Gaithersburg, Maryland);  Rachel Schneerson (Bethesda, Maryland);  Joanna Kubler-Kielb (Bethesda, Maryland);  Lily Z. Dai (Derwood, Maryland)
ABSTRACT The present disclosure relates to monoclonal antibodies that bind poly-γ-D-glutamic acid (γDPGA), which is present on the surface of Bacillus anthracis. The disclosure also provides chimeric forms of the monoclonal antibodies, humanized forms of the monoclonal antibodies, and fragments thereof, as well as nucleic acids encoding the antibodies and fragments thereof. Pharmaceutical compositions including such antibodies are also disclosed herein. The disclosure further provides prophylactic, therapeutic, and diagnostic methods of using the disclosed antibodies.
FILED Thursday, January 21, 2016
APPL NO 15/003719
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/07 (20130101)
A61K 39/40 (20130101)
A61K 39/3955 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/1278 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/54 (20130101)
C07K 2317/55 (20130101)
C07K 2317/92 (20130101)
C07K 2317/565 (20130101)
C07K 2317/622 (20130101)
C07K 2317/624 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56911 (20130101)
G01N 2333/32 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845356 Freeman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts);  President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Gordon J. Freeman (Brookline, Massachusetts);  Arlene H. Sharpe (Brookline, Massachusetts)
ABSTRACT The present invention is based, in part, on the identification of novel antibodies that have binding affinity for both PD-L1 and PD-L2 and methods of using same. In one aspect, an isolated monoclonal antibody, or antigen-binding fragment thereof, which specifically binds both PD-L1 and PD-L2, is provided. In one embodiment, both PD-L1 and PD-L2 are human PD-L1 and human PD-L2.
FILED Friday, August 02, 2013
APPL NO 14/418536
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0278 (20130101)
A01K 2227/105 (20130101)
A01K 2267/01 (20130101)

Peptides
C07K 16/2803 (20130101) Original (OR) Class
C07K 16/2827 (20130101)
C07K 2317/31 (20130101)
C07K 2317/33 (20130101)
C07K 2317/34 (20130101)
C07K 2317/56 (20130101)
C07K 2317/76 (20130101)
C07K 2317/565 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6872 (20130101)
G01N 33/57492 (20130101)
G01N 2333/70503 (20130101)
G01N 2800/56 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845357 Nishimura et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Stephen Nishimura (Mill Valley, California);  Jianlong Lou (San Bruno, California);  Jody Lynn Baron (Mill Valley, California);  James D. Marks (Kensington, California)
ABSTRACT The present invention relates to αvβ8 antagonists, anti-αvβ8 antibodies or immunoconjugates for reducing TGFβ activation in an individual. Further provided are compositions comprising one of the αvβ8 antagonists, anti-αvβ8 antibodies or immunoconjugates, methods for using the compositions, and related subject matter.
FILED Thursday, January 21, 2016
APPL NO 15/003642
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Peptides
C07K 16/2839 (20130101) Original (OR) Class
C07K 2317/34 (20130101)
C07K 2317/76 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6854 (20130101)
G01N 2333/70546 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845358 Ravetch et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Jeffrey V. Ravetch (New York, New York);  Andrew Pincetic (New York, New York)
ASSIGNEE(S) The Rockefeller University (New York, New York)
INVENTOR(S) Jeffrey V. Ravetch (New York, New York);  Andrew Pincetic (New York, New York)
ABSTRACT This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
FILED Wednesday, March 04, 2015
APPL NO 14/638905
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Peptides
C07K 16/2851 (20130101) Original (OR) Class
C07K 2317/41 (20130101)
C07K 2317/52 (20130101)
C07K 2317/70 (20130101)
C07K 2317/72 (20130101)
C07K 2318/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845360 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore, Maryland)
ASSIGNEE(S) UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore, Maryland)
INVENTOR(S) Lai-Xi Wang (Ellicott City, Maryland);  Wei Huang (Dundalk, Maryland)
ABSTRACT The present invention provides for recombinant Endo-S mutants that exhibit reduced hydrolysis activity and increased transglycosylation activity for the synthesis of glycoproteins wherein a desired sialylated oxazoline or synthetic oligosaccharide oxazoline is added to a core fucosylated or nonfucosylated GlcNAc-protein acceptor. Such recombinant Endo-S mutants are useful for efficient glycosylation remodeling of IgG1-Fc domain to provide different antibody glycoforms carrying structurally well-defined Fc N-glycans.
FILED Tuesday, September 06, 2016
APPL NO 15/256854
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/4863 (20130101)
A61K 47/48561 (20130101)

Peptides
C07K 16/00 (20130101)
C07K 16/18 (20130101)
C07K 16/2887 (20130101) Original (OR) Class
C07K 2317/10 (20130101)
C07K 2317/14 (20130101)
C07K 2317/41 (20130101)
C07K 2317/52 (20130101)
C07K 2317/72 (20130101)
C07K 2317/92 (20130101)
C07K 2317/94 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)
C12N 9/2402 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/005 (20130101)

Enzymes
C12Y 302/01096 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845415 Stansbury
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado)
ASSIGNEE(S) The Regents of the University of Colorado, A Body Corporate (Denver, Colorado)
INVENTOR(S) Jeffrey W. Stansbury (Centennial, Colorado)
ABSTRACT The present invention relates to preparation and use of water dispersible nanogels and solvent dispersible reactive nanogels as additives to enhance polymer properties or as precursors to polymeric networks.
FILED Friday, March 15, 2013
APPL NO 14/386873
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 220/18 (20130101)
C08F 220/20 (20130101)
C08F 222/1006 (20130101)
C08F 265/06 (20130101)
C08F 2220/306 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 9/00 (20130101)
C08J 2205/02 (20130101)
C08J 2333/14 (20130101)

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 133/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845457 Marbán et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Cedars-Sinai Medical Center (Los Angeles, California)
ASSIGNEE(S) Cedars-Sinai Medical Center (Los Angeles, California)
INVENTOR(S) Eduardo Marbán (Beverly Hills, California);  Tao-Sheng Li (Nanchang, China PRC)
ABSTRACT The present application relates to methods and compositions for the generation of therapeutic cells having reduced incidence of karyotypic abnormalities. In several embodiments cardiac stem cells are cultured in an antioxidant-supplemented media that reduces levels of reactive oxygen species, but does not down regulate DNA repair mechanisms. In several embodiments, physiological oxygen concentrations are used during culture in order to increase the proliferation of stem cells, decrease the senescence of the cells, decrease genomic instability, and/or augment the functionality of such cells for cellular therapies.
FILED Monday, December 28, 2015
APPL NO 14/981533
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0657 (20130101)
C12N 5/0662 (20130101) Original (OR) Class
C12N 2500/02 (20130101)
C12N 2500/38 (20130101)
C12N 2501/998 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845465 Annex et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) Brian H. Annex (Charlottesville, Virginia);  Charles R. Farber (Charlottesville, Virginia);  Surovi Hazarika (Charlottesville, Virginia)
ABSTRACT The present application discloses roles for miR-93 in treating hypoxia and ischemia. Endothelial cells (HUVEC) and myocytes (C2C12) expressed miR-93 and up-regulated miR-93 in response to hypoxia and serum starvation. Over-expression of miR-93 in HUVECs promoted cell proliferation, prevented hypoxia-induced apoptosis, and enhanced endothelial cell tube formation. miR-93 knockdown in HUVECs resulted in increased hypoxia-induced apoptosis and decreased tube formation. Over-expression or knockdown of miR-93 in myocytes resulted in reduced or increased hypoxia-induced apoptosis, respectively. Down-regulation of miR-93 in C57BL/6 mice with antagomiR resulted in attenuated perfusion recovery (% non-ischemic leg at day-21: Scramble 85.22.9 vs. AntagomiR-93 67.96). Over-expression of miR-93 in BALB/C mice improved perfusion recovery (% non-ischemic leg at day 21: PremiR-93 757.5 vs. Scramble 59.62.5). The present invention encompasses the use of miR-93 and regulation of miR-93 to treat and prevent hypoxia, ischemia, and other injuries, diseases, disorders, and conditions associated with ischemia.
FILED Thursday, August 15, 2013
APPL NO 14/421950
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/113 (20130101)
C12N 2310/141 (20130101)
C12N 2320/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845467 Liang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Ionis Pharmaceuticals, Inc. (Carlsbad, California);  Cold Spring Harbor Laobratory (Cold Spring Harbor, New York)
ASSIGNEE(S) Ionis Pharmaceuticals, Inc. (Carlsbad, California);  Cold Spring Harbor Laboratory (Cold Spring Harbor, New York)
INVENTOR(S) Xue-hai Liang (Del Mar, California);  Stanley T. Crooke (Carlsbad, California);  C. Frank Bennett (Carlsbad, California);  David L. Spector (Cold Spring Harbor, New York)
ABSTRACT The present invention provides compounds and methods for modulating target nucleic acids found in organelles or sub-organelles of cells. The invention includes, but is not limited to compounds and methods that modulate target nucleic acids in a sub-nuclear organelle, such as the nucleolus and/or a cajal body. In certain embodiments, the cell is in an animal.
FILED Friday, March 04, 2016
APPL NO 15/061843
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/315 (20130101)
C12N 2310/321 (20130101)
C12N 2310/322 (20130101)
C12N 2310/341 (20130101)
C12N 2310/351 (20130101)
C12N 2310/3231 (20130101)
C12N 2310/3521 (20130101)
C12N 2310/3525 (20130101)
C12N 2310/3533 (20130101)
C12N 2320/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845471 Hingorani
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Fred Hutchinson Cancer Research Center (Seattle, Washington)
ASSIGNEE(S) Fred Hutchinson Cancer Research Center (Seattle, Washington)
INVENTOR(S) Sunil R. Hingorani (Seattle, Washington)
ABSTRACT The present disclosure provides compositions and methods for treating or reducing the risk of pancreatic cancer by administering compounds capable of inhibiting the expression or activity of RUNX3.
FILED Tuesday, January 14, 2014
APPL NO 14/760940
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 38/00 (20130101)
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/1135 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)
C12N 2320/30 (20130101)
C12N 2320/31 (20130101)
C12N 2740/15041 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845472 Ogunwobi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
APPLICANT(S) Research Foundation of the City University of New York (New York, New York)
ASSIGNEE(S) Research Foundation of the City University of New York (New York, New York)
INVENTOR(S) Olorunseun O. Ogunwobi (Yonkers, New York);  Adeodat Ilboudo (Bronx, New York);  Chunxiao Ying (Forest Hills, New York)
ABSTRACT PVT1 exon 9 is overexpressed in aggressively tumorigenic prostate cancer cell lines and prostate tumor tissues. This exon provides a diagnostic tool for the detection and monitoring of aggressive prostate cancer. Several small interfering ribonucleic acids (siRNAs) are disclosed that are useful for treating prostate cancer.
FILED Monday, November 07, 2016
APPL NO 15/345463
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1135 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/50 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845480 Eberwine et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
INVENTOR(S) James Eberwine (Philadelphia, Pennsylvania);  Jai-Yoon Sul (Cherry Hill, New Jersey);  Tae Kyung Kim (Wynnewood, Pennsylvania);  Vickas Patel (Berwyn, Pennsylvania)
ABSTRACT The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
FILED Monday, October 12, 2015
APPL NO 14/880737
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 45/06 (20130101)
A61K 48/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0622 (20130101)
C12N 5/0657 (20130101)
C12N 15/85 (20130101) Original (OR) Class
C12N 2501/998 (20130101)
C12N 2506/00 (20130101)
C12N 2506/08 (20130101)
C12N 2506/1307 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845481 Marengo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina)
INVENTOR(S) Matthew S. Marengo (Durham, North Carolina);  Mariano A. Garcia-Blanco (Hillsborough, North Carolina)
ABSTRACT Synthetic regulation of gene expression is provided. In some embodiments, synthetic regulatory constructs are provided. In some embodiments, a synthetic regulatory construct expresses a heterologous gene in a selected cell type. In some embodiments, methods of expressing a heterologous gene in a selected cell type are provided.
FILED Monday, February 29, 2016
APPL NO 15/055880
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/85 (20130101) Original (OR) Class
C12N 2800/30 (20130101)
C12N 2830/008 (20130101)
C12N 2840/007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845482 Tilly et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) Jonathan L. Tilly (Windham, New Hampshire);  David A. Sinclair (Chestnut Hill, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts);  President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Jonathan L. Tilly (Windham, New Hampshire);  David A. Sinclair (Chestnut Hill, Massachusetts)
ABSTRACT Compositions and methods comprising bioenergetic agents for restoring the quality of aged oocytes, enhancing oogonial stem cells or improving derivatives thereof (e.g., cytoplasm or isolated mitochondria) for use in fertility-enhancing procedures, are described.
FILED Friday, April 13, 2012
APPL NO 13/447083
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/05 (20130101)
A61K 31/137 (20130101)
A61K 31/277 (20130101)
A61K 31/352 (20130101)
A61K 31/498 (20130101)
A61K 31/4745 (20130101)
A61K 35/14 (20130101)
A61K 35/28 (20130101)
A61K 35/51 (20130101)
A61K 35/54 (20130101)

Heterocyclic Compounds
C07D 213/50 (20130101)
C07D 233/60 (20130101)
C07D 233/88 (20130101)
C07D 277/36 (20130101)
C07D 277/64 (20130101)
C07D 277/587 (20130101)
C07D 495/04 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0609 (20130101)
C12N 5/0682 (20130101)
C12N 15/873 (20130101) Original (OR) Class
C12N 2501/40 (20130101)
C12N 2517/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845497 Quake et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
NIH Office of the Director (NIHOD)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Stephen R. Quake (Stanford, California);  Thomas M. Snyder (Palo Alto, California);  Hannah Valantine (Stanford, California)
ABSTRACT The invention provides methods, devices, compositions and kits for diagnosing or predicting transplant status or outcome in a subject who has received a transplant.
FILED Monday, February 24, 2014
APPL NO 14/188455
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101) Original (OR) Class
C12Q 1/6837 (20130101)
C12Q 1/6869 (20130101)
C12Q 1/6883 (20130101)
C12Q 2600/106 (20130101)

Electric Digital Data Processing
G06F 19/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845499 Hung et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Combinati Incorporated (Palo Alto, California)
ASSIGNEE(S) COMBINATI INCORPORATED (Palo Alto, California)
INVENTOR(S) Ju-Sung Hung (Palo Alto, California);  Andrew Zayac (San Leandro, California);  Megan Dueck (San Diego, California)
ABSTRACT A microfluidic device can have a plurality of microchambers connected to a microchannel via siphon apertures. The microfluidic device may be formed from a thermoplastic and capped by a thermoplastic thin film. The microfluidic device may be used for digital polymerase chain reactions by forcing reagent into the microchambers at low pressure via an inlet, forcing any gas trapped in the microfluidic device to outgas through the thin film by applying high pressure to the microfluidic device via inlets and outlets of the microfluidic device, and applying air at low pressure to the inlets in order to digitize the chambers such that the reagent in each chamber is isolated from the reagent in other chambers by an air gap. After digitization, the device may be used to run a digital polymerase chain reaction process.
FILED Tuesday, November 29, 2016
APPL NO 15/363896
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50273 (20130101)
B01L 3/502707 (20130101)
B01L 3/502715 (20130101)
B01L 2200/12 (20130101)
B01L 2300/12 (20130101)
B01L 2300/041 (20130101)
B01L 2300/0832 (20130101)
B01L 2300/0864 (20130101)
B01L 2400/0487 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846155 Rissin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Quanterix Corporation (Lexington, Massachusetts)
ASSIGNEE(S) Quanterix Corporation (Lexington, Massachusetts)
INVENTOR(S) David M. Rissin (Somerville, Massachusetts);  David Fournier (Northborough, Massachusetts);  David C. Duffy (Arlington, Massachusetts)
ABSTRACT Described herein are systems and methods for extending the dynamic range of assay methods and systems used for determining the concentration of analyte molecules or particles in a fluid sample. In some embodiments, a method comprises spatially segregating a plurality of analyte molecules in a fluid sample into a plurality of locations. At least a portion of the locations may be addressed to determine the percentage of said locations containing at least one analyte molecule. Based at least in part on the percentage, a measure of the concentration of analyte molecules in the fluid sample may be determined using an analog, intensity-based detection/analysis method/system and/or a digital detection/analysis method/system. In some cases, the assay may comprise the use of a plurality of capture objects.
FILED Monday, August 17, 2015
APPL NO 14/827815
ART UNIT 1677 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6428 (20130101)
G01N 21/6452 (20130101)
G01N 33/573 (20130101) Original (OR) Class
G01N 33/54313 (20130101)
G01N 33/54366 (20130101)
G01N 2201/062 (20130101)
G01N 2333/924 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846157 Hahn et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Stephen M. Hahn (Glen Mills, Pennsylvania);  Jay F. Dorsey (Media, Pennsylvania);  Gary D. Kao (Wynnewood, Pennsylvania);  Emigdio Reyes (Philadelphia, Pennsylvania)
ABSTRACT A repeatable method for detecting circulating tumor cells in vitro is provided. The method involves combining a test sample from a patient suspected of having circulating tumor cells, and a non-lytic adenoviral system, and culture media for the cells. The adenoviral system utilizes (i) a first replication-defective adenoviral particle in which an expression cassette is packaged, said expression cassette comprising an adenoviral 5′ and 3′ ITRs and a tumor-specific promoter; and (ii) a coding sequence for a reporter protein which is expressed in the presence of circulating tumor cells, and an adenoviral 3′ ITR. The test sample and the non-lytic adenoviral system are incubated for a sufficient time to permit expression of the reporter protein, and measuring reporter protein expression in the test samples, whereby presence of reporter expression indicates the presence of circulating tumor cells in the sample.
FILED Thursday, March 14, 2013
APPL NO 14/438321
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502753 (20130101)
B01L 2200/0652 (20130101)
B01L 2200/0668 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0864 (20130101)
B01L 2400/086 (20130101)
B01L 2400/0487 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6897 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 30/6069 (20130101)
G01N 30/6095 (20130101)
G01N 33/574 (20130101) Original (OR) Class
G01N 33/54366 (20130101)
G01N 2030/524 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846160 Battula et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas Systems (Austin, Texas)
INVENTOR(S) Venkata Battula (Houston, Texas);  Michael Andreeff (Houston, Texas);  Sendurai A. Mani (Houston, Texas);  Tapasree Roy Sarkar (Houston, Texas)
ABSTRACT Methods for determining the presence of cancer stem cells by detecting GD2 expression. Also provided are methods for reducing proliferation of cancer stem cells by contacting the cells with a GD2 targeting agent, such as an anti-GD2 antibody or a GD3 synthase inhibitor. GD3 synthase inhibitor compounds are also provided.
FILED Wednesday, February 27, 2013
APPL NO 14/380807
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4192 (20130101)
A61K 31/4196 (20130101)
A61K 39/39558 (20130101)
A61K 45/06 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/3084 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57407 (20130101)
G01N 33/57415 (20130101)
G01N 33/57492 (20130101) Original (OR) Class
G01N 2405/10 (20130101)
G01N 2800/54 (20130101)
G01N 2800/7028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846161 Shih et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Wei-Heng Shih (Bryn Mawr, Pennsylvania);  Wan Y. Shih (Bryn Mawr, Pennsylvania);  Hui Li (Newark, Delaware);  Ian McDonald (Weatherly, Pennsylvania);  Andrew Kopek (Chagrin Falls, Ohio);  Ryan O'Malley (Norristown, Pennsylvania);  Yu-Chieh Lu (Hsinchu, Taiwan)
ASSIGNEE(S) DREXEL UNIVERSITY (Philadelphia, Pennsylvania)
INVENTOR(S) Wei-Heng Shih (Bryn Mawr, Pennsylvania);  Wan Y. Shih (Bryn Mawr, Pennsylvania);  Hui Li (Newark, Delaware);  Ian McDonald (Weatherly, Pennsylvania);  Andrew Kopek (Chagrin Falls, Ohio);  Ryan O'Malley (Norristown, Pennsylvania);  Yu-Chieh Lu (Hsinchu, Taiwan)
ABSTRACT A novel quantum dot capable of near infrared emissions at wavelengths of 750-1100 is made by forming solid solutions of metal sulfide, metal selenide or metal sulfide selenide by incorporating a suitable amount of an additional metallic element or elements to provide an emission wavelength in the range of 750 nm to 1100 nm. The quantum dots may be enabled for bioconjugation and may be used in a method for tissue imaging and analyte detection.
FILED Friday, September 12, 2014
APPL NO 14/484519
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 15/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/532 (20130101)
G01N 33/588 (20130101) Original (OR) Class

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/774 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846162 Dhodapkar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Yale University (New Haven, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Madhav Dhodapkar (New Haven, Connecticut);  Kavita Dhodapkar (New Haven, Connecticut)
ABSTRACT The present invention relates to predictors of a cancer patient's responsiveness to immunotherapy for cancer.
FILED Friday, March 08, 2013
APPL NO 14/401360
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6854 (20130101) Original (OR) Class
G01N 33/57423 (20130101)
G01N 2333/54 (20130101)
G01N 2333/525 (20130101)
G01N 2333/555 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846164 Daley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) Children's Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) George Q. Daley (Weston, Massachusetts);  In-Hyun Park (Boston, Massachusetts);  Thorsten M. Schlaeger (Brookline, Massachusetts);  Elayne Chan (Auburndale, Massachusetts);  Sutheera Ratanasirintrawoot (Boston, Massachusetts)
ABSTRACT The methods and kits described herein are based, in part, to the discovery of a phenotype representing a fully-reprogrammed iPS cell and several reprogramming intermediates. The methods and kits described herein permit identification of fully-reprogrammed iPS cells and further permits one of skill in the art to monitor the emergence of iPS cells during the reprogramming process. The methods/kits can also be performed using real time using live cell imaging. Also described herein are methods for screening candidate reprogramming agents by monitoring the emergence of fully-reprogrammed iPS cells in the presence and absence of such an agent.
FILED Friday, February 28, 2014
APPL NO 14/194586
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6881 (20130101)
C12Q 2600/124 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/53 (20130101)
G01N 33/58 (20130101)
G01N 33/502 (20130101)
G01N 33/536 (20130101)
G01N 33/577 (20130101)
G01N 33/582 (20130101)
G01N 33/5023 (20130101)
G01N 33/5044 (20130101)
G01N 33/5047 (20130101)
G01N 33/5073 (20130101)
G01N 33/6854 (20130101)
G01N 33/6872 (20130101) Original (OR) Class
G01N 33/56966 (20130101)
G01N 2333/90 (20130101)
G01N 2333/705 (20130101)
G01N 2333/70596 (20130101)
G01N 2500/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846313 Nikolenko et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Volodymyr Nikolenko (New York, New York);  Rafael Yuste (New York, New York);  Brendon O. Watson (New York, New York);  Darcy Peterka (Hoboken, New Jersey)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) Volodymyr Nikolenko (New York, New York);  Rafael Yuste (New York, New York);  Brendon O. Watson (New York, New York);  Darcy Peterka (Hoboken, New Jersey)
ABSTRACT According to exemplary embodiments of the present disclosure, it is possible to provide method, system, arrangement, computer-accessible medium and device to stimulate individual neurons in brain slices in any arbitrary spatio-temporal pattern, using two-photon uncaging of photo-sensitive compounds such as MNI-glutamate and/or RuBi-Glutamate with beam multiplexing. Such exemplary method and device can have single-cell and three-dimensional precision. For example, by sequentially stimulating up to a thousand potential presynaptic neurons, it is possible to generate detailed functional maps of inputs to a cell. In addition, it is possible to combine this exemplary approach with two-photon calcium imaging in an all-optical method to image and manipulate circuit activity. Further exemplary embodiments of the present disclosure can include a light-weight, compact portable device providing for uses in a wide variety of applications.
FILED Friday, September 25, 2009
APPL NO 13/121084
ART UNIT 2884 — Optics
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/0622 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6458 (20130101)
G01N 2021/653 (20130101)
G01N 2201/0221 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/0004 (20130101)
G02B 27/46 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846762 Torres-Roca et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) University of South Florida (Tampa, Florida)
ASSIGNEE(S) University of South Florida (Tampa, Florida)
INVENTOR(S) Javier F. Torres-Roca (St. Petersburg, Florida);  Steven Eschrich (Lakeland, Florida)
ABSTRACT Described are mathematical models and method, e.g., computer-implemented methods, for predicting tumor sensitivity to radiation therapy, which can be used, e.g., for selecting a treatment for a subject who has a tumor.
FILED Wednesday, August 28, 2013
APPL NO 14/012029
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)

Electric Digital Data Processing
G06F 19/12 (20130101) Original (OR) Class
G06F 19/20 (20130101)
G06F 19/24 (20130101)
G06F 19/3437 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847471 Snyder et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Life Services, LLC (Minneapolis, Minnesota);  Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota);  Life Services, LLC (Minneapolis, Minnesota)
INVENTOR(S) Carl J. Snyder (Minneapolis, Minnesota);  John Thomas Vaughan, Jr. (Stillwater, Minnesota);  Charles A. Lemaire (Apple Valley, Minnesota)
ABSTRACT Apparatus and method that includes providing a variable-parameter electrical component in a high-field environment and based on an electrical signal, automatically moving a movable portion of the electrical component in relation to another portion of the electrical component to vary at least one of its parameters. In some embodiments, the moving uses a mechanical movement device (e.g., a linear positioner, rotary motor, or pump). In some embodiments of the method, the electrical component has a variable inductance, capacitance, and/or resistance. Some embodiments include using a computer that controls the moving of the movable portion of the electrical component in order to vary an electrical parameter of the electrical component. Some embodiments include using a feedback signal to provide feedback control in order to adjust and/or maintain the electrical parameter. Some embodiments include a non-magnetic positioner connected to an electrical component configured to have its RLC parameters varied by the positioner.
FILED Tuesday, August 26, 2014
APPL NO 14/469527
ART UNIT 2837 — Electrical Circuits and Systems
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/3628 (20130101)
G01R 33/34092 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 41/042 (20130101) Original (OR) Class

Antennas, i.e Radio Aerials
H01Q 1/103 (20130101)
H01Q 3/02 (20130101)
H01Q 3/44 (20130101)

Electric Machines Not Otherwise Provided for
H02N 2/046 (20130101)
H02N 2/0075 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE46641 Whitehead et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Stephen S. Whitehead (Bethesda, Maryland);  Brian R. Murphy (Bethesda, Maryland);  Lewis Markoff (Bethesda, Maryland);  Barry Falgout (Rockville, Maryland);  Joseph E. Blaney (Gettysburg, Pennsylvania);  Kathryn A. Hanley (Las Cruces, New Mexico);  Ching-Juh Lai (Bethesda, Maryland)
ABSTRACT The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (Δ30) in the 3′-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4.
FILED Friday, May 17, 2013
APPL NO 13/896388
ART UNIT 3991 — Central Reexamination Unit (Chemical)
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 2039/70 (20130101)
A61K 2039/5254 (20130101)
A61K 2039/5256 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101) Original (OR) Class
C12N 2770/24134 (20130101)
C12N 2770/24161 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 09844339 Wang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Joseph Wang (San Diego, California);  Joshua Ray Windmiller (Del Mar, California)
ABSTRACT Techniques and systems are disclosed for implementing textile-based screen-printed amperometric or potentiometric sensors. The chemical sensor can include carbon based electrodes to detect at least one of NADH, hydrogen peroxide, potassium ferrocyanide, TNT or DNT, in liquid or vapor phase. In one application, underwater presence of chemicals such as heavy metals and explosives is detected using the textile-based sensors.
FILED Friday, September 04, 2015
APPL NO 14/846412
ART UNIT 1759 — Optics
CURRENT CPC
Outerwear; Protective Garments; Accessories
A41D 1/002 (20130101)

Diagnosis; Surgery; Identification
A61B 5/0002 (20130101)
A61B 5/021 (20130101)
A61B 5/0205 (20130101)
A61B 5/0245 (20130101)
A61B 5/742 (20130101)
A61B 5/1477 (20130101)
A61B 5/1486 (20130101)
A61B 5/02444 (20130101)
A61B 5/4266 (20130101)
A61B 5/4845 (20130101)
A61B 5/4884 (20130101)
A61B 5/6802 (20130101)
A61B 5/6804 (20130101) Original (OR) Class
A61B 5/6807 (20130101)
A61B 5/6808 (20130101)
A61B 5/6831 (20130101)
A61B 5/14517 (20130101)
A61B 5/14532 (20130101)
A61B 5/14546 (20130101)
A61B 2560/0214 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/001 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/308 (20130101)
G01N 27/3271 (20130101)
G01N 33/22 (20130101)
G01N 33/0057 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 1/038 (20130101)
H05K 3/1216 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844394 DiBiasio et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Children's Medical Center Corporation (Boston, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Children's Medical Center Corporation (Boston, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Christopher DiBiasio (North Providence, Rhode Island);  Keith Durand (Somerville, Massachusetts);  Jonathan Brigham Hopkins (Salt Lake City, Utah);  Zach Traina (Hingham, Massachusetts);  Alexander Slocum (Bow, New Hampshire);  Samir Nayfeh (Shrewsbury, Massachusetts);  Pedro J. del Nido (Lexington, Massachusetts);  Nikolay V. Vasilyev (Belmont, Massachusetts)
ABSTRACT The instrument ports for introducing instruments into a surgical site that are disclosed herein include a port body having a channel running therethrough from a proximal end to a distal end, an instrument sleeve in slidable contact with the channel, creating a gap therebetween, and a fluid flow element for removing emboli efficiently from the instrument port, wherein the fluid flow element includes the gap. Disclosed fluid flow systems are for use in the disclosed instrument ports. Methods are also disclosed for removably securing an instrument sleeve to a port body by anchoring the instrument port to heart tissue, making at least one flood line in a channel, flushing out emboli, and performing surgery with the instrument port.
FILED Monday, March 11, 2013
APPL NO 13/792916
ART UNIT 3731 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/0218 (20130101)
A61B 17/3421 (20130101)
A61B 17/3423 (20130101)
A61B 17/3462 (20130101)
A61B 17/3498 (20130101) Original (OR) Class
A61B 90/06 (20160201)
A61B 2017/00119 (20130101)
A61B 2017/00243 (20130101)
A61B 2017/0243 (20130101)
A61B 2017/347 (20130101)
A61B 2017/00876 (20130101)
A61B 2017/3445 (20130101)
A61B 2017/3488 (20130101)
A61B 2090/306 (20160201)
A61B 2090/373 (20160201)
A61B 2090/3614 (20160201)
A61B 2090/3925 (20160201)
A61B 2217/005 (20130101)
A61B 2217/007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844582 Wittrup et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Karl Dane Wittrup (Chestnut Hill, Massachusetts);  Byron Hua Kwan (Boston, Massachusetts);  Shuning Gai (Cambridge, Massachusetts)
ABSTRACT The present invention relates to methods of treating cancer with a combination of extended-PK IL-2 and one or more therapeutic agents, such as a therapeutic antibody. The methods of the invention are applicable across any type of cancer.
FILED Tuesday, May 21, 2013
APPL NO 14/402889
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/385 (20130101)
A61K 38/2013 (20130101) Original (OR) Class
A61K 38/2013 (20130101)
A61K 39/39533 (20130101)
A61K 45/06 (20130101)
A61K 47/48215 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845147 Emerick
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Northrop Grumman Systems Corporation (Falls Church, Virginia)
ASSIGNEE(S) Northrop Grumman Systems Corporation (Falls Church, Virginia)
INVENTOR(S) Mark F. Emerick (San Diego, California)
ABSTRACT A spoiler assembly is provided that is engageable to a UAV that defines a body, an outer surface and an inner surface. The spoiler assembly comprises a spoiler, translatably connected to the UAV inner surface adjacent a first portion of the spoiler aperture. The spoiler defines an upper surface and an outer surface, the upper surface being substantially the same size and shape as the spoiler aperture. A spoiler shroud is connected to the UAV inner surface and extends within the UAV body about at least a portion of the spoiler aperture. A spoiler activating mechanism is secured to the UAV inner surface and connected the spoiler lower surface. The mechanism is operative to translate the spoiler between a first position wherein the spoiler upper surface is substantially flush with the UAV outer surface, and second a position, wherein the spoiler upper surface is disposed substantially within the UAV body.
FILED Friday, April 25, 2014
APPL NO 14/262647
ART UNIT 3647 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeroplanes; Helicopters
B64C 21/02 (20130101) Original (OR) Class
B64C 39/10 (20130101)
B64C 2039/105 (20130101)
B64C 2230/06 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/166 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845166 London et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Ventions, LLC (San Francisco, California)
ASSIGNEE(S) Ventions, LLC (San Francisco, California)
INVENTOR(S) Adam P London (San Francisco, California);  Bevan Gerber-Siff (San Francisco, California)
ABSTRACT A rail-captive sled for deploying payloads into outer space from a space launch vehicle. The sled is driven by a piston, powered by residual tank pressure from a tank native to the space launch vehicle. The rails are arranged parallel and adapted to a cross-sectional shape of a payload, such as small satellites or cubesats. The sled is a box frame sled with an adaptation to receive the piston. The rails may be attached to the residual pressure tank, with the piston in the residual pressure tank and aligned to the rails, or the pressure may be drawn from tank plumbing to a cylinder specific to the piston. The rails have a releasable closure to avoid unplanned egress of the payload, and the closure locks in the open position once released. The piston may be constrained by a direct constraint or by the closure via the payload.
FILED Monday, June 01, 2015
APPL NO 14/726896
ART UNIT 3643 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Cosmonautics; Vehicles or Equipment Therefor
B64G 1/402 (20130101)
B64G 1/641 (20130101)
B64G 1/645 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845229 Wade et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America as represented by the Department of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) James Wade (Waldorf, Maryland);  Matthew Gebstadt (King George, Virginia);  Mike Sharp (King George, Virginia);  Lee Foltz (Indian Head, Maryland);  Angel Diaz (Indian Head, Maryland)
ABSTRACT An apparatus for lifting a buried explosive device includes a T-shaped base including a flange member and a web member. The web member has one end fixed at a right angle to the midpoint of the flange member. A vertical upright member is fixed at one end to the midpoint of the flange member. A diagonal member is fixed at one end to the other end of the vertical upright member and fixed at another end to a second end of the web member that is distal the flange member. The vertical upright member is at least twice a length of the web member. The flange member, the web member, the vertical upright member and the diagonal member are L-channel members made of carbon fiber.
FILED Friday, April 29, 2016
APPL NO 14/999362
ART UNIT 3632 — Static Structures, Supports and Furniture
CURRENT CPC
Cranes; Load-engaging Elements or Devices for Cranes, Capstans, Winches, or Tackles
B66C 1/34 (20130101)

Hoisting, Lifting, Hauling or Pushing, Not Otherwise Provided For, e.g Devices Which Apply a Lifting or Pushing Force Directly to the Surface of a Load
B66F 11/00 (20130101)
B66F 19/00 (20130101) Original (OR) Class

Frames, Casings or Beds of Engines, Machines or Apparatus, Not Specific to Engines, Machines or Apparatus Provided for Elsewhere; Stands; Supports
F16M 11/2014 (20130101)

Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 11/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845252 Kwak et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Rhokyun Kwak (Cambridge, Massachusetts);  Jongyoon Han (Bedford, Massachusetts)
ABSTRACT Between two juxtaposed similar ion exchange membranes (AEMs or CEMs), an ion depletion zone (dde) and ion enrichment zone (den) are generated under an electric field. As cations are selectively transferred through the CEMs, for example, anions are relocated in order to achieve electro-neutrality, resulting in the concentration drop (increase) in ion depletion (enrichment) zone. The concentration drop (i.e. salt removal) is low and spatially gradual at relatively low voltage or current (i.e. Ohmic regime). However, at higher voltage or current (i.e. overlimiting regime), strong electroconvective vortex accelerates cation transport through CEMs, allowing us to “relocate” most salt ions. The flat depletion zone occurs with significantly low ion concentration, and corresponding strong electric field in the zone, and any charged agents (e.g. proteins and bacteria) cannot penetrate this flat zone. As a result, we can separate and collect the desalted/purified flow from brine flow by bifurcating the channel at the end of the CEMs. This ICP desalination/purification also happens with two anion exchange membranes (AEMs) by relocating cations, but the location of desalted/brine flows are converted.
FILED Tuesday, June 17, 2014
APPL NO 14/306607
ART UNIT 1756 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Separation
B01D 61/42 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/469 (20130101) Original (OR) Class
C02F 2103/08 (20130101)
C02F 2201/46115 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845409 Dressick et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Walter J. Dressick (Waldorf, Maryland);  Melik C. Demirel (State College, Pennsylvania)
ABSTRACT Provided herein are the polymers shown below. The value n is a positive integer. R1 is an organic group, and each R2 is H or a chemisorbed group, with at least one R2 being a chemisorbed group. The polymer may be a nanostructured film. Also provided herein is a method of: converting a di-p-xylylene paracyclophane dimer to a reactive vapor of monomers; depositing the reactive vapor onto a substrate held at an angle relative to the vapor flux to form nanostructured poly(p-xylylene) film; reacting the film with an agent to form hydrogen atoms that are reactive with a precursor of a chemisorbed group, if the film does not contain the hydrogen atoms; and reacting the hydrogen atoms with the precursor. Also provided herein is a device having a nanostructured poly(p-xylylene) film on a pivotable substrate. The film has directional hydrophobic or oleophobic properties and directional adhesive properties.
FILED Tuesday, July 26, 2016
APPL NO 15/219925
ART UNIT 1764 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/38 (20130101)
B05D 1/60 (20130101)
B05D 5/08 (20130101)
B05D 5/10 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 283/004 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 61/025 (20130101)
C08G 81/00 (20130101)
C08G 2261/61 (20130101)
C08G 2261/3424 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 155/00 (20130101)
C09D 165/04 (20130101) Original (OR) Class

Adhesives; Non-mechanical Aspects of Adhesive Processes in General; Adhesive Processes Not Provided for Elsewhere; Use of Materials as Adhesives
C09J 7/00 (20130101)
C09J 2201/626 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2835 (20150115)
Y10T 428/31504 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845436 Harvey
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Benjamin G. Harvey (Ridgecrest, California)
ABSTRACT A method for producing high density fuels from isoprene which can be produced via biosynthetic routes using biomass sugars as feedstock. This allows for the production of isoprene and isoprene-derived fuels from abundant waste materials with the potential to significantly reduce DoD carbon emissions. Embodiments of the invention describe a method for conversion of isoprene to full performance jet and diesel fuels. Isoprene can be selectively oligomerized to generate a distribution of branched chain hydrocarbons. Combination of an oligomerization catalyst with a metathesis catalyst allows for the synthesis of high density cyclic fuels with performance advantages (increased density and volumetric net heat of combustion) over conventional petroleum-based fuels.
FILED Thursday, May 19, 2016
APPL NO 15/158762
ART UNIT 1771 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Cracking Hydrocarbon Oils; Production of Liquid Hydrocarbon Mixtures, e.g by Destructive Hydrogenation, Oligomerisation, Polymerisation; Recovery of Hydrocarbon Oils From Oil-shale, Oil-sand, or Gases; Refining Mixtures Mainly Consisting of Hydrocarbons; Reforming of Naphtha; Mineral Waxes
C10G 69/126 (20130101) Original (OR) Class

Fuels Not Otherwise Provided for; Natural Gas; Synthetic Natural Gas Obtained by Processes Not Covered by Subclasses C10G, C10K; Liquefied Petroleum Gas; Adding Materials to Fuels or Fires to Reduce Smoke or Undesirable Deposits or to Facilitate Soot Removal; Firelighters
C10L 1/04 (20130101)
C10L 1/08 (20130101)
C10L 1/1608 (20130101)
C10L 2200/043 (20130101)
C10L 2270/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845520 Wright et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Warfare Center (NAWC)
APPLICANT(S) James A. Wright (Chicago, Illinois);  Abhijeet Misra (Evanston, Illinois)
ASSIGNEE(S) Questek Innovations LLC (Evanston, Illinois)
INVENTOR(S) James A. Wright (Chicago, Illinois);  Abhijeet Misra (Evanston, Illinois)
ABSTRACT A beryllium-free high-strength copper alloy includes, about 10-30 vol % of L12-(Ni,Cu)3(Al,Sn), and substantially excludes cellular discontinuous precipitation around grain boundaries. The alloy may include at least one component selected from the group consisting of: Ag, Cr, Mn, Nb, Ti, and V, and the balance Cu.
FILED Tuesday, March 31, 2009
APPL NO 12/415510
ART UNIT 1734 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Alloys
C22C 9/06 (20130101) Original (OR) Class

Changing the Physical Structure of Non-ferrous Metals and Non-ferrous Alloys
C22F 1/08 (20130101)

Shafts; Flexible Shafts; Elements or Crankshaft Mechanisms; Rotary Bodies Other Than Gearing Elements; Bearings
F16C 33/121 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845524 Snyder
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) Brooks E. Snyder (Glastonbury, Connecticut)
ABSTRACT The present disclosure relates generally to a fixture for use in applying a coating to a multiple vane nozzle for use in a turbomachine. The fixture includes first and second masks that are applied to opposite sides of the nozzle to mimic the geometry and spacing of the vanes of the nozzle.
FILED Wednesday, December 31, 2014
APPL NO 14/587841
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 4/01 (20160101) Original (OR) Class
C23C 4/134 (20160101)
C23C 14/22 (20130101)
C23C 14/042 (20130101)

Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/288 (20130101)
F01D 9/04 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/672 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845551 Tour et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) James M. Tour (Bellaire, Texas);  Zheng Yan (Houston, Texas)
ASSIGNEE(S) WILLIAM MARSH RICE UNIVERSITY (Houston, Texas)
INVENTOR(S) James M. Tour (Bellaire, Texas);  Zheng Yan (Houston, Texas)
ABSTRACT In some embodiments, the present disclosure pertains to methods of forming single-crystal graphenes by: (1) cleaning a surface of a catalyst; (2) annealing the surface of the catalyst; (3) applying a carbon source to the surface of the catalyst; and (4) growing single-crystal graphene on the surface of the catalyst from the carbon source. Further embodiments of the present disclosure also include a step of separating the formed single-crystal graphene from the surface of the catalyst. In some embodiments, the methods of the present disclosure also include a step of transferring the formed single-crystal graphene to a substrate. Additional embodiments of the present disclosure also include a step of growing stacks of single crystals of graphene.
FILED Wednesday, July 10, 2013
APPL NO 13/939086
ART UNIT 1714 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/0453 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 25/02 (20130101)
C30B 25/186 (20130101) Original (OR) Class
C30B 29/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845554 Zhang et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Advanced Technology Program (NIST-ATP)
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Mei Zhang (Tallahassee, Florida);  Shaoli Fang (Richardson, Texas);  Ray H. Baughman (Dallas, Texas);  Anvar A. Zakhidov (McKinney, Texas);  Ali E. Aliev (Dallas, Texas);  Sergey Li (Dallas, Texas);  Chris Williams (Dallas, Texas)
ABSTRACT The present invention is directed to nanofiber yarns, ribbons, and sheets; to methods of making said yarns, ribbons, and sheets; and to applications of said yarns, ribbons, and sheets. In some embodiments, the nanotube yarns, ribbons, and sheets comprise carbon nanotubes. Particularly, such carbon nanotube yarns of the present invention provide unique properties and property combinations such as extreme toughness, resistance to failure at knots, high electrical and thermal conductivities, high absorption of energy that occurs reversibly, up to 13% strain-to-failure compared with the few percent strain-to-failure of other fibers with similar toughness, very high resistance to creep, retention of strength even when heated in air at 450° C. for one hour, and very high radiation and UV resistance, even when irradiated in air. Furthermore these nanotube yarns can be spun as one micron diameter yarns and plied at will to make two-fold, four-fold, and higher fold yarns. Additional embodiments provide for the spinning of nanofiber sheets having arbitrarily large widths. In still additional embodiments, the present invention is directed to applications and devices that utilize and/or comprise the nanofiber yarns, ribbons, and sheets of the present invention.
FILED Friday, February 26, 2016
APPL NO 15/055395
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 5/02 (20130101)
B32B 5/12 (20130101)
B32B 37/12 (20130101)
B32B 2262/106 (20130101)
B32B 2307/202 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/0293 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/50 (20130101)

Chemical Features in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons; Apparatus Specially Adapted for the Manufacture of Carbon Filaments
D01F 9/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845686 Spangler
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
INVENTOR(S) Brandon W. Spangler (Vernon, Connecticut)
ABSTRACT An airfoil having an overlapping herringbone filmhole pattern is disclosed. For instance, the airfoil may have filmholes arranged in filmrows, each filmrow divided into groups of filmholes. A first group may be oriented to direct cooling air generally radially outward over a surface of the airfoil and a second group may be oriented to direct cooling air generally radially inward over a surface of the airfoil. Between the first group and the second group of filmholes in each filmrow, a transition region exists. A transition region filmrow group may be disposed within the transition region and may be co-linear with or staggered relative to the first group and/or the second group. In this manner, the transition region filmrow group enhances the effectiveness of the cooling proximate to the transition region.
FILED Friday, May 08, 2015
APPL NO 14/707875
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/186 (20130101) Original (OR) Class
F01D 9/065 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2240/121 (20130101)
F05D 2240/303 (20130101)
F05D 2260/202 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/672 (20130101)
Y02T 50/676 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845692 Jamison
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S) General Electric Company (Schenectady, New York)
INVENTOR(S) Joshua Brian Jamison (Liberty Township, Ohio)
ABSTRACT A turbine component assembly for a gas turbine engine includes: a first component having a first coefficient of thermal expansion and including an end face; a second component including a mating surface abutting the end face; and a fastener having a second coefficient of thermal expansion different from the first coefficient of thermal expansion, the fastener including a shank engaging the second component and an enlarged head engaging a mounting slot in the first component; wherein the mating surface and the end face shaped to permit relative pivoting movement between the first and second components.
FILED Tuesday, May 05, 2015
APPL NO 14/704406
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/284 (20130101)
F01D 9/041 (20130101)
F01D 9/042 (20130101) Original (OR) Class
F01D 25/005 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2230/642 (20130101)
F05D 2240/128 (20130101)
F05D 2250/42 (20130101)
F05D 2250/711 (20130101)
F05D 2260/36 (20130101)
F05D 2300/17 (20130101)
F05D 2300/6033 (20130101)
F05D 2300/50212 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/672 (20130101)
Y02T 50/673 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845693 Spangler
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) United Technologies Corporation (Hartford, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
INVENTOR(S) Brandon W. Spangler (Vernon, Connecticut)
ABSTRACT A surface structure having an overlapping herringbone filmhole pattern is disclosed. For instance, the surface structure may have filmholes arranged in filmrows, each filmrow divided into groups of filmholes. A first group may be oriented to direct cooling air generally outward over a surface of the surface structure and a second group may be oriented to direct cooling air generally inward over a surface of the surface structure. Between the first group and the second group of filmholes in each filmrow, a transition region exists. A transition region filmrow group may be disposed within the transition region and may be collinear with or staggered relative to the first group and/or the second group. In this manner, the transition region filmrow group enhances the effectiveness of the cooling proximate to the transition region.
FILED Monday, August 10, 2015
APPL NO 14/822334
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/186 (20130101)
F01D 9/042 (20130101) Original (OR) Class
F01D 9/065 (20130101)
F01D 25/12 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2240/11 (20130101)
F05D 2240/81 (20130101)
F05D 2260/202 (20130101)

Generating Combustion Products of High Pressure or High Velocity, e.g Gas-turbine Combustion Chambers
F23R 3/002 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/672 (20130101)
Y02T 50/676 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845694 Hagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) Benjamin F. Hagan (Manchester, Connecticut);  Ryan Alan Waite (Glastonbury, Connecticut);  Bryan P. Dube (Columbia, Connecticut);  Lane Thornton (Ellington, Connecticut)
ABSTRACT An assembly for a gas turbine engine according to an exemplary aspect of the present disclosure includes, among other things, an airfoil including a radial end, a first passageway having an outlet at the radial end, and a second passageway having an inlet at the radial end. The assembly further includes a cover having at least one turning cavity configured to direct fluid expelled from the outlet of the first passageway into the inlet of the second passageway.
FILED Wednesday, April 22, 2015
APPL NO 14/693359
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/147 (20130101)
F01D 5/186 (20130101)
F01D 5/187 (20130101)
F01D 5/188 (20130101)
F01D 9/041 (20130101)
F01D 9/065 (20130101) Original (OR) Class

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2240/81 (20130101)
F05D 2240/125 (20130101)
F05D 2240/307 (20130101)
F05D 2250/75 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/676 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845727 Suciu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
APPLICANT(S) Gabriel L. Suciu (Glastonbury, Connecticut);  James W. Norris (Lebanon, Connecticut);  Brian Merry (Andover, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Gabriel L. Suciu (Glastonbury, Connecticut);  James W. Norris (Lebanon, Connecticut);  Brian Merry (Andover, Connecticut)
ABSTRACT A non-metallic tailcone (202) in a tip turbine engine includes a tapered wall structure disposed (208) about a central axis. The non-metallic tailcone is fastened to a structural frame (44) in the aft portion of the tip turbine engine. The tip turbine engine produces a first temperature gas stream from a first output source and a second temperature gas stream from a second output source. The second temperature gas stream is a lower temperature than the first temperature gas stream. The second temperature gas stream is discharged at an inner diameter of the tip turbine engine over an outer surface of the tailcone. Discharging the cooler second temperature gas stream at the inner diameter allows a non-metallic to be used to form the tailcone.
FILED Wednesday, December 01, 2004
APPL NO 11/720463
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 3/073 (20130101) Original (OR) Class

Jet-propulsion Plants
F02K 1/04 (20130101)
F02K 3/068 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2300/603 (20130101)
F05D 2300/614 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/672 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49346 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845731 Birnkrant et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) United Technologies Corporation (Hartford, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) Michael J. Birnkrant (Kenilworth, New Jersey);  Carey Clum (East Hartford, Connecticut)
ABSTRACT Systems and methods are disclosed herein for passively managing cooling air in a gas turbine engine. A cooling air supply line may supply cooling air to a component in the gas turbine engine. A metering coupon may have a negative coefficient of thermal expansion. The metering coupon may allow more airflow through the metering coupon and through the component in response to an increase in temperature.
FILED Wednesday, June 24, 2015
APPL NO 14/749438
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/182 (20130101)
F01D 5/186 (20130101)
F01D 9/041 (20130101)
F01D 11/08 (20130101)
F01D 11/14 (20130101)
F01D 11/24 (20130101)
F01D 25/12 (20130101)

Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/18 (20130101)
F02C 7/20 (20130101) Original (OR) Class
F02C 7/25 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2240/12 (20130101)
F05D 2240/30 (20130101)
F05D 2240/35 (20130101)
F05D 2240/55 (20130101)
F05D 2260/202 (20130101)
F05D 2300/16 (20130101)
F05D 2300/134 (20130101)
F05D 2300/5021 (20130101)
F05D 2300/50212 (20130101)

Generating Combustion Products of High Pressure or High Velocity, e.g Gas-turbine Combustion Chambers
F23R 3/002 (20130101)
F23R 3/06 (20130101)
F23R 3/26 (20130101)
F23R 2900/03042 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 23/02 (20130101)
G05D 23/021 (20130101)
G05D 23/022 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845850 Claffee et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
APPLICANT(S) iRobot Corporation (Bedford, Massachusetts)
ASSIGNEE(S) iRobot Corporation (Bedford, Massachusetts)
INVENTOR(S) Mark R. Claffee (Methuen, Massachusetts);  Timothy R. Ohm (Grover Beach, California);  Erik Amaral (Lexington, Massachusetts);  Annan M. Mozeika (Andover, Massachusetts)
ABSTRACT A robot includes a support, a movable member coupled to the support to permit gimbal rotation about a pitch axis and a yaw axis, and first and second linear actuators connected to each of the support and the movable member and operable to rotate the movable member about the pitch axis and the yaw axis. The first linear actuator is pivotally attached to the movable member at a first pivot point. The second linear actuator is pivotally attached to the movable member at a second pivot point. The first and second pivot points are each angularly offset from the pitch axis and the yaw axis by about 45 degrees and are located on the same side of the pitch axis.
FILED Friday, January 30, 2015
APPL NO 14/610013
ART UNIT 2837 — Electrical Circuits and Systems
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 17/0266 (20130101)

Gearing
F16H 25/20 (20130101) Original (OR) Class
F16H 2025/2062 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846011 Clark et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Alan Clark (Tucson, Arizona);  Aaron C. Lattimore (Tucson, Arizona)
ABSTRACT A motion analysis system includes an acceleration measuring device, an acceleration processor, a velocity processor, a distance processor, a peak velocity processor, a profile correlation processor, and a vehicle action processor. The system determines a time for an initiation of an action for a vehicle by determining that a distance traveled by the vehicle is greater than a safe separation distance and that a peak velocity is greater than a minimum velocity. The system initiates the action for the vehicle based on the verified position of the vehicle and the confirmed profile data as determined by the profile correlation processor, and based on the determination that the distance traveled by the vehicle is greater than the safe separation distance and that the peak velocity is greater than the minimum velocity as determined by the vehicle action processor.
FILED Friday, October 21, 2016
APPL NO 15/331157
ART UNIT 3663 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Weapon Sights; Aiming
F41G 7/001 (20130101) Original (OR) Class
F41G 9/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846017 Hooke et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Ryan Hooke (Bangor, Pennsylvania);  Tyler Myers (Lebanon, New Jersey)
ABSTRACT A high pressure obturator for a breech loaded, tube-launched projectile includes a generally annular ring having a central longitudinal axis and a radially inward portion. A flange portion is disposed radially outward of and partially contiguous with the radially inward portion. The flange portion extends axially forward and aft beyond the radially inward portion. The outer diameter of the flange portion decreases linearly from an aft most outer diameter to a forward most outer diameter. The obturator may be formed of a plastic material and include circumferential wraps of a high-strength fiber completely embedded in grooves in the obturator.
FILED Thursday, April 17, 2014
APPL NO 14/255301
ART UNIT 3675 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Preparation or Pretreatment of the Material to be Shaped; Making Granules or Preforms; Recovery of Plastics or Other Constituents of Waste Material Containing Plastics
B29B 11/04 (20130101)
B29B 11/08 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 70/682 (20130101)
B29C 70/683 (20130101)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2031/26 (20130101)
B29L 2031/777 (20130101)

Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 14/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846055 Boser et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Bernhard E. Boser (Berkeley, California);  Mitchell H. Kline (Oakland, California);  Igor Izyumin (Oakland, California);  Yu-Ching Yeh (Berkeley, California);  Burak Eminoglu (Berkeley, California)
ABSTRACT A vibratory gyroscope system is described which utilizes a mechanical resonator having a first mode of vibration and an associated first natural frequency, and a second mode of vibration having an associated second natural frequency. The angular rate of motion input couples energy between the first and second modes of vibration. The gyroscope has driver circuits, sensors and actuators for the first and second modes. The invention utilizes a bias error shifting method which provides for shifting the bias error away from DC to a higher frequency, where it can be removed by low pass filtering. As a result of the inventive method, gyroscope systems can be produced with significantly lower bias error.
FILED Thursday, October 15, 2015
APPL NO 14/884606
ART UNIT 2852 — Printing/Measuring and Testing
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 19/5705 (20130101)
G01C 19/5726 (20130101)
G01C 19/5776 (20130101)
G01C 25/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846163 McGrath et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Materiel Development Activity (USAMMDA)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Tricol Biomedical, Inc. (Portland, Oregon)
ASSIGNEE(S) Tricol Biomedical, Inc. (Portland, Oregon)
INVENTOR(S) Barbara McGrath (Portland, Oregon);  Simon McCarthy (Portland, Oregon);  Sam Kuhn (Portland, Oregon);  Alysha Wold (Portland, Oregon);  Michael Stolten (Portland, Oregon);  Amanda Bennett (Portland, Oregon)
ABSTRACT The invention relates to biocompatible, bioabsorbable derivatized non-crosslinked chitosan compositions optionally crosslinked to gelatin/collagen by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) for biomedical use and methods of making and testing such compositions, including a modified acute systemic toxicity test. The compositions comprise derivatized chitosan reacetylated to a degree of N-deacetylation (DDA) of between about 15% and 40%. The compositions are typically bioabsorbed in about 90 days or less and can be made to bioabsorb at differing rates of speed. The compositions are initially soluble in aqueous solution below pH 6.5. The compositions have an acid content that can be adjusted between about 0% (w/w) and about 8% (w/w) to customize the composition for uses that require and/or tolerate differing levels of cytotoxicity, adhesion, composition cohesion, and cell infiltration into the composition.
FILED Wednesday, March 04, 2015
APPL NO 14/638770
ART UNIT 1673 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101)
A61K 47/36 (20130101)
A61K 49/0008 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/20 (20130101)
A61L 27/20 (20130101)
A61L 27/26 (20130101)
A61L 27/26 (20130101)

Polysaccharides; Derivatives Thereof
C08B 37/003 (20130101)

Compositions of Macromolecular Compounds
C08L 5/08 (20130101)
C08L 5/08 (20130101)
C08L 5/08 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6869 (20130101) Original (OR) Class
G01N 2333/545 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846223 Hellwig et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) CHESAPEAKE TECHNOLOGY INTERNATIONAL CORPORATION (California, Maryland)
ASSIGNEE(S) CHESAPEAKE TECHNOLOGY INTERNATIONAL CORPORATION (California, Maryland)
INVENTOR(S) Dustan Christopher Hellwig (Monument, Colorado);  Matthew Gene Goldsbury (Camarillo, California);  Thomas Marshall Tucker (Waxhaw, North Carolina)
ABSTRACT Systems, devices, and methods efficiently calculate optimal flight paths for protected entities given terrain data, aircraft position, flight characteristics, and positions of known threat emitters. The systems and methods execute within the mission planning timeline, and the developed processes allow users to retrieve data from the calculations to effectively place an electronic attack platform at the right place and at the right time to be effective. The calculated optimal flight paths are displayed or otherwise visualized in the mission space. Electronic attack jamming capabilities are combined with projected threat emitter performance information in order to obtain optimal geometrical positioning of the electronic attack relative to the threat emitter. Threat emitter system characteristics are combined with electronic attack aircraft capabilities while simultaneously incorporating the position of the protected entity aircraft and rendered to assist the electronic attack aircrew in providing optimal electronic attack capabilities to protect one or more entities.
FILED Thursday, March 13, 2014
APPL NO 14/208771
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/021 (20130101)
G01S 7/36 (20130101)
G01S 7/38 (20130101) Original (OR) Class
G01S 7/537 (20130101)
G01S 7/2813 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 1/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846717 Pike et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Galois, Inc. (Portland, Oregon)
ASSIGNEE(S) Galois, Inc. (Portland, Oregon)
INVENTOR(S) Lee Pike (Portland, Oregon);  Patrick Christopher Hickey (Portland, Oregon);  Aaron Tomb (Portland, Oregon);  Eric Mertens (Portland, Oregon)
ABSTRACT Various technologies related to control flow integrity checking are described herein and can be used to greatly improve software security. During static analysis, a canonical control flow graph can be built. Execution of a program can be interrupted at runtime, and the call stack can be observed to verify control flow integrity of the program using the canonical control flow graph. Attacks using stack tampering can be avoided, regardless of how the stack tampering is achieved. Non-invasive techniques can be used, making the technologies applicable in situations where source code is not available. Real-time operating system protection can be supported.
FILED Tuesday, October 22, 2013
APPL NO 14/060506
ART UNIT 2431 — Cryptography and Security
CURRENT CPC
Electric Digital Data Processing
G06F 11/3604 (20130101)
G06F 17/30371 (20130101) Original (OR) Class
G06F 21/52 (20130101)
G06F 21/566 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846762 Torres-Roca et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) University of South Florida (Tampa, Florida)
ASSIGNEE(S) University of South Florida (Tampa, Florida)
INVENTOR(S) Javier F. Torres-Roca (St. Petersburg, Florida);  Steven Eschrich (Lakeland, Florida)
ABSTRACT Described are mathematical models and method, e.g., computer-implemented methods, for predicting tumor sensitivity to radiation therapy, which can be used, e.g., for selecting a treatment for a subject who has a tumor.
FILED Wednesday, August 28, 2013
APPL NO 14/012029
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)

Electric Digital Data Processing
G06F 19/12 (20130101) Original (OR) Class
G06F 19/20 (20130101)
G06F 19/24 (20130101)
G06F 19/3437 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846785 Bacon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) David F. Bacon (Sleepy Hollow, New York);  Graham A. Bent (Hursley, United Kingdom);  Flavio A. Bergamaschi (Southampton, United Kingdom);  Wei Zhang (Egham, United Kingdom)
ABSTRACT A querying node generates public keys, secret keys, and switch key matrices. A public key associated with a first level and the switch key matrices are sent to a receiving node. The receiving node generates a key-value table, mapping values to keys, and encodes the keys and values using a polynomial ring of a predetermined type. The querying node encodes using a polynomial ring of the same predetermined type, then encrypts a query, using a public key, and sends the query to the receiving node. The receiving node performs a homomorphic comparison of the encrypted, encoded query with each encoded key entry in the encoded key-value store to determine a comparison result. The receiving node sums the results for each of the value entries and returns the summed result to the querying node. The querying node decrypts and decodes the received result using the corresponding secret key.
FILED Wednesday, November 25, 2015
APPL NO 14/952717
ART UNIT 2435 — Cryptography and Security
CURRENT CPC
Electric Digital Data Processing
G06F 21/6227 (20130101) Original (OR) Class

Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/008 (20130101)
H04L 9/14 (20130101)
H04L 9/321 (20130101)
H04L 9/3093 (20130101)
H04L 2209/24 (20130101)
H04L 2209/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847034 Plawecki
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Daniel W. Plawecki (Ocala, Florida)
ASSIGNEE(S) Northrop Grumman Systems Corporation (Falls Church, Virginia)
INVENTOR(S) Daniel W. Plawecki (Ocala, Florida)
ABSTRACT An aerial vehicle maneuvers in compliance with applicable aviation regulations by formulating a request to air traffic control (ATC) for permission to perform a proposed maneuver, overlaying, as a sub-modulated secondary signal, data characterizing the request on top of a primary ADS-B signal such that the primary ADS-B signal is not interfered with, and transmitting an ADS-B message comprising the primary and secondary signals. Permission can likewise be transmitted and received from ATC using ADS-B overlay communication. The aerial vehicle can conduct emergency maneuvers in the absence of permission and update ATC as to flight path deviations taken using ADS-B overlay communication, without the need for a voice radio and by using existing ADS-B digital communications.
FILED Friday, September 02, 2016
APPL NO 15/256256
ART UNIT 3661 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Traffic Control Systems
G08G 5/0008 (20130101)
G08G 5/0021 (20130101)
G08G 5/0039 (20130101)
G08G 5/045 (20130101)
G08G 5/0069 (20130101) Original (OR) Class

Transmission
H04B 7/18506 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847121 Frank
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) David J. Frank (Yorktown Heights, New York)
ABSTRACT A quantum mechanical radio frequency (RF) signaling system includes a transmission line that receives and conducts an RF pulse signal operating at a radio frequency, a first qubit having a quantum mechanical state that is a linear combination of at least two quantum mechanical eigenstates, and a first network of reactive electrical components having an input that is coupled to the transmission line for receiving the RF pulse signal and an output that is coupled to the first qubit. The first network of reactive electrical components attenuates the amplitude of the RF pulse signal and produces a first attenuated RF pulse signal that is applied to the first qubit. The first attenuated RF pulse signal operates at the radio frequency and has a first attenuated amplitude that causes a predefined change in the linear combination of at least two quantum mechanical eigenstates within the first qubit.
FILED Sunday, September 13, 2015
APPL NO 14/852614
ART UNIT 2631 — Digital Communications
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 99/002 (20130101)

Static Stores
G11C 11/44 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847275 Chainer et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Timothy J. Chainer (Putnam Valley, New York);  Pritish R. Parida (Fishkill, New York);  Fanghao Yang (Ossining, New York)
ABSTRACT A method of forming metallic pillars between a fluid inlet and outlet for two-phase fluid cooling. The method may include; forming an arrangement of metallic pillars between two structures, the metallic pillars are electrically connected to metallic connecting lines that run through each of the two structures, the arrangement of metallic pillars located between a fluid inlet and a fluid channel, the fluid channel having channel walls running between arrangements of the metallic pillars and a fluid outlet, whereby a fluid passes through the arrangement of metallic pillars to flow into the fluid channel.
FILED Monday, December 21, 2015
APPL NO 14/976135
ART UNIT 2899 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/4882 (20130101)
H01L 23/02 (20130101)
H01L 23/427 (20130101)
H01L 23/473 (20130101) Original (OR) Class
H01L 23/3675 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847568 Abraham et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) David W. Abraham (Cronton on Hudson, New York);  Antonio D. Corcoles Gonzalez (Mount Kisco, New York);  James R. Rozen (Peekskill, New York)
ABSTRACT A filter is provided and includes potting material formed into a body defining a through-hole. The body includes first and second opposing faces and a sidewall extending between the first and second opposing faces. The sidewall is formed to define first and second openings at opposite ends of the through-hole, first angles at an interface between the sidewall and the first face and second angles, which complement the first angles, at an interface between the sidewall and the second face.
FILED Wednesday, June 24, 2015
APPL NO 14/748501
ART UNIT 1744 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 39/10 (20130101)

Waveguides; Resonators, Lines, or Other Devices of the Waveguide Type
H01P 1/202 (20130101)
H01P 3/06 (20130101)
H01P 11/005 (20130101)
H01P 11/007 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 29/49018 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847582 Moulder et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
Office of the Under Secretary of Defense for Research and Engineering (OUSD R&E)
MIT Lincoln Laboratory (MITLL)
Federally Funded Research and Development Center (FFRDC)
Operated by Massachusetts Institute of Technology (MIT) at Lexington, MA
APPLICANT(S) William F. Moulder (Nashua, New Hampshire);  Bradley T. Perry (Nashua, New Hampshire);  Jeffrey S. Herd (Rowley, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) William F. Moulder (Nashua, New Hampshire);  Bradley T. Perry (Nashua, New Hampshire);  Jeffrey S. Herd (Rowley, Massachusetts)
ABSTRACT An antenna system capable of achieving simultaneous transmit and receive (STAR) operation over a wide bandwidth includes a ring array of TEM horn elements and a centrally located monocone or bicone antenna. The TEM horn elements each include a capacitive feed. The elements of the ring array are excited using a phasing scheme that results in signal cancellation at the location of the central element. The ring array may serve as either the transmit antenna or the receive antenna.
FILED Thursday, September 11, 2014
APPL NO 14/483516
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/525 (20130101)
H01Q 5/40 (20150115)
H01Q 9/28 (20130101)
H01Q 13/02 (20130101) Original (OR) Class
H01Q 21/28 (20130101)
H01Q 21/205 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847599 Concilio et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Andrew Nicholas Concilio (Tucson, Arizona);  Stephen K. Bliss (Tucson, Arizona);  Robert J. Di Tolla (Tucson, Arizona);  Trent N. Henderson (Tucson, Arizona);  Robert J. Hanold (Tucson, Arizona);  Andrea Toso (Parma, Italy);  E. Russ Althof (Tucson, Arizona)
ABSTRACT A cam-lock fastening system is designed to accommodate a tolerance stackup to fasten a pair of rigid structures. A spring allows some longitudinal motion of the pin that would not be accommodated by the rigid structures or metal cam-lock and pin. The spring-loaded pin is also suitably designed to produce a preloaded structural joint that is between specified minimum and maximum loads for any tolerance stackup that is within specification. The fastening of the structures requires no manual adjustment of the pin, and facilitates blind connection of a high-fidelity electrical connector. Further, the described cam-lock fastening system is designed for high performance applications requiring preload forces in the thousands of pounds per square inch.
FILED Friday, October 17, 2014
APPL NO 14/517432
ART UNIT 3679 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Devices for Fastening or Securing Constructional Elements or Machine Parts Together, e.g Nails, Bolts, Circlips, Clamps, Clips, Wedges, Joints or Jointing
F16B 12/2036 (20130101)
F16B 21/04 (20130101)

Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 15/00 (20130101)
F42B 15/36 (20130101)

Electrically-conductive Connections; Structural Associations of a Plurality of Mutually-insulated Electrical Connecting Elements; Coupling Devices; Current Collectors
H01R 13/62905 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847632 Zivi et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Daniel F. Zivi (Severna Park, Maryland);  David W. Kinnard (Olney, Maryland)
ASSIGNEE(S) Northrup Grumman Systems Corporation (Falls Church, Virginia)
INVENTOR(S) Daniel F. Zivi (Severna Park, Maryland);  David W. Kinnard (Olney, Maryland)
ABSTRACT A cable termination system and method include providing an outer socket having a frustum shaped socket interior tapering from a base to a top opening. The outer socket is comprised of two semicircular socket pieces, each forming a portion of a complete circumference of the outer socket. A plurality of elongate cable strands extend through the socket interior with individual strands circumferentially spaced to form a single layer of strands at the base opening. A frustoconical inner plug is inserted into the socket by a compressive force exceeding a maximum tensile force of the stranded cable for holding the cable in the socket without slippage when a tensile force is applied between the cable and the outer socket. The inner plug includes a plurality of longitudinally extending, laterally separate plug subassemblies.
FILED Tuesday, November 24, 2015
APPL NO 14/951262
ART UNIT 3677 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Belts, Cables, or Ropes, Predominantly Used for Driving Purposes; Chains; Fittings Predominantly Used Therefor
F16G 11/02 (20130101)

Installation of Electric Cables or Lines, or of Combined Optical and Electric Cables or Lines
H02G 15/007 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 09844589 Haynes et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
APPLICANT(S) Barton F. Haynes (Durham, North Carolina);  Feng Gao (Durham, North Carolina);  Bette T. Korber (Los Alamos, New Mexico);  Beatrice H. Hahn (Birmingham, Alabama);  George M. Shaw (Birmingham, Alabama);  Denise Kothe (Birmingham, Alabama);  Ying Ying Li (Hoover, Alabama);  Julie Decker (Alabaster, Alabama);  Hua-Xin Liao (Chapel Hill, North Carolina)
ASSIGNEE(S) DUKE UNIVERSITY (Durham, North Carolina);  THE UNIVERSITY OF ALABAMA BIRMINGHAM RESEARCH FOUNDATION (Birmingham, Alabama);  LOS ALAMOS NATIONAL SECURITY, LLC (Los Alamos, New Mexico)
INVENTOR(S) Barton F. Haynes (Durham, North Carolina);  Feng Gao (Durham, North Carolina);  Bette T. Korber (Los Alamos, New Mexico);  Beatrice H. Hahn (Birmingham, Alabama);  George M. Shaw (Birmingham, Alabama);  Denise Kothe (Birmingham, Alabama);  Ying Ying Li (Hoover, Alabama);  Julie Decker (Alabaster, Alabama);  Hua-Xin Liao (Chapel Hill, North Carolina)
ABSTRACT The invention relates to HIV-1 envelope polypeptides comprising the consensus envelope of SEQ ID NO: 35, compositions comprising these envelopes and methods for using same.
FILED Tuesday, August 23, 2011
APPL NO 13/137517
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class
A61K 2039/53 (20130101)
A61K 2039/57 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 16/4225 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/15022 (20130101)
C12N 2740/15034 (20130101)
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16222 (20130101)
C12N 2740/16322 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844590 Korber et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
APPLICANT(S) LOS ALAMOS NATIONAL SECURITY, LLC (Los Alamos, New Mexico);  BETH ISRAEL DEACONESS MEDICAL CENTER (Boston, Massachusetts);  DUKE UNIVERSITY (Durham, North Carolina);  THE UAB RESEARCH FOUNDATION (Birmingham, Alabama)
ASSIGNEE(S) Duke University (Durham, North Carolina);  Los Alamos National Security, LLC (Los Alamos, New Mexico);  Beth Israel Deconess Medical Center (Boston, Massachusetts);  The UAB Research Foundation (Birmingham, Alabama)
INVENTOR(S) Bette T. Korber (Los Alamos, New Mexico);  William Fischer (Los Alamos, New Mexico);  Norman Letvin (Boston, Massachusetts);  Hua-Xin Liao (Durham, North Carolina);  Barton F. Haynes (Durham, North Carolina);  Beatrice H. Hahn (Birmingham, Alabama)
ABSTRACT The present invention relates, in general, to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same. The invention further relates to methods that use a genetic algorithm to create sets of polyvalent antigens suitable for use, for example, in vaccination strategies.
FILED Friday, May 29, 2015
APPL NO 14/726373
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class
A61K 2039/53 (20130101)
A61K 2039/70 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/24143 (20130101)
C12N 2740/16022 (20130101)
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16234 (20130101)
C12N 2740/16334 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844762 Worsley et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Marcus A. Worsley (Hayward, California);  Joe Satcher (Patterson, California);  Sergei Kucheyev (Oakland, California);  Supakit Charnvanichborikarn (Livermore, California);  Jeffrey Colvin (Pleasanton, California);  Thomas Felter (Livermore, California);  Sangil Kim (Pleasanton, California);  Matthew Merrill (Dublin, California);  Christine Orme (Oakland, California)
ABSTRACT Described here is a metal-carbon composite, comprising (a) a porous three-dimensional scaffold comprising one or more of carbon nanotubes, graphene and graphene oxide, and (b) metal nanoparticles disposed on said porous scaffold, wherein the metal-carbon composite has a density of 1 g/cm3 or less, and wherein the metal nanoparticles account for 1 wt. % or more of the metal-carbon composite. Also described are methods for making the metal-carbon composite.
FILED Friday, September 12, 2014
APPL NO 14/485474
ART UNIT 1731 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 13/0091 (20130101) Original (OR) Class

Non-metallic Elements; Compounds Thereof;
C01B 31/022 (20130101)
C01B 31/043 (20130101)
C01B 31/0253 (20130101)
C01B 31/0438 (20130101)
C01B 31/0484 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2006/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844990 Hobart et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Clinton G. Hobart (Albuquerque, New Mexico);  William D. Morse (Albuquerque, New Mexico);  Robert James Bickerstaff (Albuquerque, New Mexico)
ABSTRACT A MEUV that is able to navigate aerial, aquatic, and terrestrial environments through the use of different mission mobility attachments is disclosed. The attachments allow the MEUV to be deployed from the air or through the water prior to any terrestrial navigation. The mobility attachments can be removed or detached by and from the vehicle during a mission.
FILED Wednesday, February 01, 2017
APPL NO 15/422252
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Vehicles for Use Both on Rail and on Road; Amphibious or Like Vehicles; Convertible Vehicles
B60F 3/003 (20130101)
B60F 3/0007 (20130101)
B60F 5/02 (20130101) Original (OR) Class
B60F 5/006 (20130101)

Offensive or Defensive Arrangements on Vessels; Mine-laying; Mine-sweeping; Submarines; Aircraft Carriers
B63G 8/001 (20130101)
B63G 8/08 (20130101)
B63G 2008/004 (20130101)

Aeroplanes; Helicopters
B64C 37/00 (20130101)
B64C 39/024 (20130101)
B64C 2201/00 (20130101)
B64C 2201/021 (20130101)
B64C 2201/028 (20130101)
B64C 2201/082 (20130101)
B64C 2201/121 (20130101)
B64C 2201/126 (20130101)
B64C 2201/127 (20130101)
B64C 2201/146 (20130101)
B64C 2211/00 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 47/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845239 Wallace et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Intelligent Energy Limited (Loughborough, United Kingdom)
ASSIGNEE(S) Intelligent Energy Limited (Loughborough, United Kingdom)
INVENTOR(S) Andrew P. Wallace (Davis, California);  John M. Melack (Winters, California);  Michael Lefenfeld (New York, New York)
ABSTRACT Systems, devices, and methods combine thermally stable reactant materials and aqueous solutions to generate hydrogen and a non-toxic liquid by-product. The reactant materials can sodium silicide or sodium silica gel. The hydrogen generation devices are used in fuels cells and other industrial applications. One system combines cooling, pumping, water storage, and other devices to sense and control reactions between reactant materials and aqueous solutions to generate hydrogen. Springs and other pressurization mechanisms pressurize and deliver an aqueous solution to the reaction. A check valve and other pressure regulation mechanisms regulate the pressure of the aqueous solution delivered to the reactant fuel material in the reactor based upon characteristics of the pressurization mechanisms and can regulate the pressure of the delivered aqueous solution as a steady decay associated with the pressurization force. The pressure regulation mechanism can also prevent hydrogen gas from deflecting the pressure regulation mechanism.
FILED Wednesday, July 01, 2015
APPL NO 14/789880
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 7/02 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 3/06 (20130101) Original (OR) Class
C01B 3/065 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/362 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845334 Feng et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Patrick L. Feng (Livermore, California);  Joseph S. Carlson (Morgan Hill, California)
ABSTRACT A new family of neutron/gamma discriminating scintillators is disclosed that comprises stable organic glasses that may be melt-cast into transparent monoliths. These materials have been shown to provide light yields greater than solution-grown trans-stilbene crystals and efficient PSD capabilities when combined with 0.01 to 0.05% by weight of the total composition of a wavelength-shifting fluorophore. Photoluminescence measurements reveal fluorescence quantum yields that are 2 to 5 times greater than conventional plastic or liquid scintillator matrices, which accounts for the superior light yield of these glasses. The unique combination of high scintillation light-yields, efficient neutron/gamma PSD, and straightforward scale-up via melt-casting distinguishes the developed organic glasses from existing scintillators.
FILED Monday, October 10, 2016
APPL NO 15/289611
ART UNIT 2884 — Optics
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 209/08 (20130101)
C07C 211/54 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/0809 (20130101)
C07F 7/0827 (20130101)
C07F 9/46 (20130101) Original (OR) Class

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/06 (20130101)
C09K 2211/1011 (20130101)
C09K 2211/1014 (20130101)

Measurement of Nuclear or X-radiation
G01T 1/20 (20130101)
G01T 3/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845441 Erdemir et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UChicago Argonne, LLC (Chicago, Illinois)
ASSIGNEE(S) UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Ali Erdemir (Naperville, Illinois);  Osman Levent Eryilmaz (Plainfield, Illinois);  Mustafa Urgen (Istanbul, Turkey);  Kursat Kazmanli (Istanbul, Turkey)
ABSTRACT A nanocomposite coating and method of making and using the coating. The nanocomposite coating is disposed on a base material, such as a metal or ceramic; and the nanocomposite consists essentially of a matrix of an alloy selected from the group of Cu, Ni, Pd, Pt and Re which are catalytically active for cracking of carbon bonds in oils and greases and a grain structure selected from the group of borides, carbides and nitrides.
FILED Monday, February 01, 2016
APPL NO 15/012667
ART UNIT 1771 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 27/22 (20130101)
B01J 27/24 (20130101)
B01J 35/002 (20130101)
B01J 37/0225 (20130101)
B01J 37/347 (20130101)
B01J 37/349 (20130101)

Lubricating Compositions; Use of Chemical Substances Either Alone or as Lubricating Ingredients in a Lubricating Composition
C10M 103/04 (20130101)
C10M 125/02 (20130101)
C10M 169/04 (20130101) Original (OR) Class
C10M 2201/05 (20130101)
C10M 2201/061 (20130101)
C10M 2201/087 (20130101)

Indexing Scheme Associated With Subclass C10M Relating to Lubricating Compositions
C10N 2210/01 (20130101)
C10N 2210/02 (20130101)
C10N 2210/03 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845478 Han et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) Kyung-Hwan Han (Okemos, Michigan);  Jae-Heung Ko (Yongin-si, South Korea)
ASSIGNEE(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
INVENTOR(S) Kyung-Hwan Han (Okemos, Michigan);  Jae-Heung Ko (Yongin-si, South Korea)
ABSTRACT The invention provides promoter sequences that regulate specific expression of operably linked sequences in developing xylem cells and/or in developing xylem tissue. The developing xylem-specific sequences are exemplified by the DX5, DX8, DX11, and DX15 promoters, portions thereof, and homologs thereof. The invention further provides expression vectors, cells, tissues and plants that contain the invention's sequences. The compositions of the invention and methods of using them are useful in, for example, improving the quantity (biomass) and/or the quality (wood density, lignin content, sugar content etc.) of expressed biomass feedstock products that may be used for bioenergy, biorefinary, and generating wood products such as pulp, paper, and solid wood.
FILED Tuesday, September 13, 2011
APPL NO 13/821095
ART UNIT 1662 — Plants
CURRENT CPC
Peptides
C07K 14/415 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/82 (20130101)
C12N 15/113 (20130101)
C12N 15/8216 (20130101)
C12N 15/8223 (20130101) Original (OR) Class
C12N 15/8226 (20130101)
C12N 15/8227 (20130101)
C12N 15/8246 (20130101)
C12N 15/8255 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845711 Ernst et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) CUMMINS INC. (Columbus, Indiana)
ASSIGNEE(S) Cummins Inc. (Columbus, Indiana);  PACCAR, Inc. (Bellevue, Washington)
INVENTOR(S) Timothy C. Ernst (Columbus, Indiana);  James A. Zigan (Versailles, Indiana)
ABSTRACT A waste heat recovery system includes a Rankine cycle (RC) circuit having a pump, a boiler, an energy converter, and a condenser fluidly coupled via conduits in that order, to provide additional work. The additional work is fed to an input of a gearbox assembly including a capacity for oil by mechanically coupling to the energy converter to a gear assembly. An interface is positioned between the RC circuit and the gearbox assembly to partially restrict movement of oil present in the gear assembly into the RC circuit and partially restrict movement of working fluid present in the RC circuit into the gear assembly. An oil return line is fluidly connected to at least one of the conduits fluidly coupling the RC components to one another and is operable to return to the gear assembly oil that has moved across the interface from the gear assembly to the RC circuit.
FILED Friday, May 24, 2013
APPL NO 13/902719
ART UNIT 3748 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Steam Engine Plants; Steam Accumulators; Engine Plants Not Otherwise Provided For; Engines Using Special Working Fluids or Cycles
F01K 9/00 (20130101) Original (OR) Class
F01K 25/04 (20130101)
F01K 25/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846229 Doerry et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technologies and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Armin W. Doerry (Albuquerque, New Mexico);  Douglas L. Bickel (Albuquerque, New Mexico);  Richard M. Naething (Albuquerque, New Mexico);  Volker Horndt (San Diego, California)
ABSTRACT The various technologies presented herein relate to utilizing direction of arrival (DOA) data to determine various flight parameters for an aircraft A plurality of radar images (e.g., SAR images) can be analyzed to identify a plurality of pixels in the radar images relating to one or more ground targets. In an embodiment, the plurality of pixels can be selected based upon the pixels exceeding a SNR threshold. The DOA data in conjunction with a measurable Doppler frequency for each pixel can be obtained. Multi-aperture technology enables derivation of an independent measure of DOA to each pixel based on interferometric analysis. This independent measure of DOA enables decoupling of the aircraft velocity from the DOA in a range-Doppler map, thereby enabling determination of a radar velocity. The determined aircraft velocity can be utilized to update an onboard INS, and to keep it aligned, without the need for additional velocity-measuring instrumentation.
FILED Wednesday, March 11, 2015
APPL NO 14/645131
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 13/605 (20130101)
G01S 13/9035 (20130101) Original (OR) Class
G01S 2013/9041 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846348 Luk et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Ting S. Luk (Albuquerque, New Mexico);  Michael B. Sinclair (Albuqueruqe, New Mexico);  Salvatore Campione (Albuquerque, New Mexico)
ABSTRACT Efficient harmonic light generation can be achieved with ultrathin films by coupling an incident pump wave to an epsilon-near-zero (ENZ) mode of the thin film. As an example, efficient third harmonic generation from an indium tin oxide nanofilm (λ/42 thick) on a glass substrate for a pump wavelength of 1.4 μm was demonstrated. A conversion efficiency of 3.3×10−6 was achieved by exploiting the field enhancement properties of the ENZ mode with an enhancement factor of 200. This nanoscale frequency conversion method is applicable to other plasmonic materials and reststrahlen materials in proximity of the longitudinal optical phonon frequencies.
FILED Wednesday, February 10, 2016
APPL NO 15/040799
ART UNIT 2874 — Optics
CURRENT CPC
Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/37 (20130101)
G02F 1/353 (20130101) Original (OR) Class
G02F 1/3556 (20130101)
G02F 2001/354 (20130101)
G02F 2202/16 (20130101)
G02F 2202/30 (20130101)
G02F 2202/101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847149 Spoerke et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) Sandia Corporation (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Erik David Spoerke (Albuquerque, New Mexico);  Jon Ihlefeld (Albuquerque, New Mexico);  Karen Waldrip (Albuquerque, New Mexico);  Jill S. Wheeler (Albuquerque, New Mexico);  Harlan James Brown-Shaklee (Albuquerque, New Mexico);  Leo J. Small (Albuquerque, New Mexico);  David R. Wheeler (Albuquerque, New Mexico)
ABSTRACT A purification method that uses ion-selective ceramics to electrochemically filter waste products from a molten salt. The electrochemical method uses ion-conducting ceramics that are selective for the molten salt cations desired in the final purified melt, and selective against any contaminant ions. The method can be integrated into a slightly modified version of the electrochemical framework currently used in pyroprocessing of nuclear wastes.
FILED Friday, February 26, 2016
APPL NO 15/054766
ART UNIT 1754 — Semiconductors/Memory
CURRENT CPC
Separation
B01D 61/44 (20130101)
B01D 69/02 (20130101)
B01D 71/024 (20130101)
B01D 2325/14 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/447 (20130101)
C04B 35/495 (20130101)
C04B 35/632 (20130101)
C04B 35/634 (20130101)
C04B 35/638 (20130101)
C04B 35/6261 (20130101)
C04B 2111/00801 (20130101)
C04B 2235/76 (20130101)
C04B 2235/761 (20130101)
C04B 2235/764 (20130101)
C04B 2235/3201 (20130101)
C04B 2235/3203 (20130101)
C04B 2235/3215 (20130101)
C04B 2235/3227 (20130101)
C04B 2235/3244 (20130101)
C04B 2235/3251 (20130101)
C04B 2235/3418 (20130101)
C04B 2235/6562 (20130101)
C04B 2235/6587 (20130101)
C04B 2235/9669 (20130101)

Production and Refining of Metals; Pretreatment of Raw Materials
C22B 15/0026 (20130101)
C22B 26/10 (20130101)
C22B 26/20 (20130101)

Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation or Particle Bombardment; Treating Radioactively Contaminated Material; Decontamination Arrangements Therefor
G21F 9/12 (20130101) Original (OR) Class
G21F 9/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847174 Zhang et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S) General Electric Company (Niskayuna, New York)
INVENTOR(S) Lili Zhang (Niskayuna, New York);  Daniel Qi Tan (Rexford, New York);  Jeffrey S Sullivan (Rexford, New York)
ABSTRACT A capacitor assembly is disclosed. The capacitor assembly includes a housing. The capacitor assembly further includes a plurality of capacitors disposed within the housing. Furthermore, the capacitor assembly includes a thermally conductive article disposed about at least a portion of a capacitor body of the capacitors, and in thermal contact with the capacitor body. Moreover, the capacitor assembly also includes a heat sink disposed within the housing and in thermal contact with at least a portion of the housing and the thermally conductive article such that the heat sink is configured to remove heat from the capacitor in a radial direction of the capacitor assembly. Further, a method of forming the capacitor assembly is also presented.
FILED Wednesday, December 09, 2015
APPL NO 14/964120
ART UNIT 2848 — Electrical Circuits and Systems
CURRENT CPC
Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 4/38 (20130101)
H01G 4/224 (20130101)
H01G 4/258 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847215 Degtiarenko
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Thomas Jefferson National Accelerator Facility (TJNAF)
Federally Funded Research and Development Center (FFRDC)
Operated by Jefferson Science Associates, LLC (JSA) at Newport News, VA
APPLICANT(S) JEFFERSON SCIENCE ASSOCIATES, LLC (Newport News, Virginia)
ASSIGNEE(S) JEFFERSON SCIENCE ASSOCIATES, LLC (Newport News, Virginia)
INVENTOR(S) Pavel V. Degtiarenko (Williamsburg, Virginia)
ABSTRACT An environmental radiation detector for detecting and distinguishing between all types of environmental radiation, including photons, charged particles, and neutrons. A large volume high pressure ionization chamber (HPIC) includes BF3 gas at a specific concentration to render the radiation detector sensitive to the reactions of neutron capture in Boron-10 isotope. A pulse-mode readout is connected to the ionization chamber capable of measuring both the height and the width of the pulse. The heavy charged products of the neutron capture reaction deposit significant characteristic energy of the reaction in the immediate vicinity of the reaction in the gas, producing a signal with a pulse height proportional to the reaction energy, and a narrow pulse width corresponding to the essentially pointlike energy deposition in the gas. Readout of the pulse height and the pulse width parameters of the signals enables distinguishing between the different types of environmental radiation, such as gamma (x-rays), cosmic muons, and neutrons.
FILED Thursday, October 22, 2015
APPL NO 14/919826
ART UNIT 2884 — Optics
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 1/185 (20130101)
G01T 3/008 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 47/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847487 Forrest et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
Office of Science (DOE-SC)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Stephen R. Forrest (Ann Arbor, Michigan);  Jeramy D. Zimmerman (Golden, Colorado);  Brian E Lassiter (San Francisco, California);  Xin Xiao (Ann Arbor, Michigan)
ABSTRACT Disclosed herein are methods for fabricating an organic photovoltaic device comprising depositing an amorphous organic layer and a crystalline organic layer over a first electrode, wherein the amorphous organic layer and the crystalline organic layer contact one another at an interface; annealing the amorphous organic layer and the crystalline organic layer for a time sufficient to induce at least partial crystallinity in the amorphous organic layer; and depositing a second electrode over the amorphous organic layer and the crystalline organic layer. In the methods and devices herein, the amorphous organic layer may comprise at least one material that undergoes inverse-quasi epitaxial (IQE) alignment to a material of the crystalline organic layer as a result of the annealing.
FILED Friday, November 22, 2013
APPL NO 14/646136
ART UNIT 2898 — Semiconductors/Memory
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/001 (20130101)
H01L 51/0003 (20130101)
H01L 51/0026 (20130101) Original (OR) Class
H01L 51/0028 (20130101)
H01L 51/0046 (20130101)
H01L 51/0053 (20130101)
H01L 51/0059 (20130101)
H01L 51/0062 (20130101)
H01L 51/4253 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847531 Abdelmalak et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Michael Naguib Abdelmalak (Knoxville, Tennessee);  Srikanth Allu (Oak Ridge, Tennessee);  Nancy J. Dudney (Knoxville, Tennessee);  Jianlin Li (Knoxville, Tennessee);  Srdjan Simunovic (Knoxville, Tennessee);  Hsin Wang (Knoxville, Tennessee)
ABSTRACT A battery electrode assembly includes a current collector with conduction barrier regions having a conductive state in which electrical conductivity through the conduction barrier region is permitted, and a safety state in which electrical conductivity through the conduction barrier regions is reduced. The conduction barrier regions change from the conductive state to the safety state when the current collector receives a short-threatening event. An electrode material can be connected to the current collector. The conduction barrier regions can define electrical isolation subregions. A battery is also disclosed, and methods for making the electrode assembly, methods for making a battery, and methods for operating a battery.
FILED Tuesday, December 01, 2015
APPL NO 14/955366
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/13 (20130101)
H01M 4/70 (20130101) Original (OR) Class
H01M 4/661 (20130101)
H01M 4/667 (20130101)
H01M 10/0525 (20130101)
H01M 10/4235 (20130101)
H01M 2004/027 (20130101)
H01M 2004/028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 09844383 Allen
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Embolx, Inc. (Sunnyvale, California)
ASSIGNEE(S) Embolx, Inc. (Sunnyvale, California)
INVENTOR(S) Michael P. Allen (Los Altos, California)
ABSTRACT A method of transarterial embolization agent delivery at a low pressure is provided. The method comprises advancing a delivery device with an occlusion structure in a retracted non-occlusive configuration through a supply artery to a vascular position in the supply artery that is in the vicinity of a target anatomical structure, the target structure having terminal capillary beds, expanding the occlusion structure from the retracted non-occlusive configuration to an expanded occlusive configuration, lowering a mean arterial pressure in a vascular space distal to the expanded occlusion structure, redirecting fluid flow from the collateral vessels toward the lowered pressure vascular space and into the target anatomical structure, injecting an embolization agent through the delivery device and into the lowered pressure vascular space, and delivering the embolization agent from the lowered pressure vascular space into the target anatomical structure. Other catheter assemblies and methods of use are also disclosed.
FILED Tuesday, July 05, 2016
APPL NO 15/202391
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/1204 (20130101)
A61B 17/12109 (20130101)
A61B 17/12136 (20130101)
A61B 17/12186 (20130101) Original (OR) Class
A61B 2017/1205 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 25/10 (20130101)
A61M 25/0068 (20130101)
A61M 25/0069 (20130101)
A61M 25/1002 (20130101)
A61M 2005/1726 (20130101)
A61M 2025/0003 (20130101)
A61M 2025/0076 (20130101)
A61M 2025/1052 (20130101)
A61M 2025/1061 (20130101)
A61M 2025/1081 (20130101)
A61M 2025/1093 (20130101)
A61M 2025/1097 (20130101)
A61M 2210/166 (20130101)
A61M 2210/1433 (20130101)
A61M 2230/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844585 Olbricht et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
APPLICANT(S) William L. Olbricht (Ithaca, New York);  Keith B. Neeves (Philadelphia, Pennsylvania);  Conor Foley (Ithaca, New York);  Russell T. Matthews (Skaneateles, New York);  W. Mark Saltzman (New Haven, Connecticut);  Andrew Sawyer (New Haven, Connecticut)
ASSIGNEE(S) YALE UNIVERSITY (New Haven, Connecticut);  CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) William L. Olbricht (Ithaca, New York);  Keith B. Neeves (Philadelphia, Pennsylvania);  Conor Foley (Ithaca, New York);  Russell T. Matthews (Skaneateles, New York);  W. Mark Saltzman (New Haven, Connecticut);  Andrew Sawyer (New Haven, Connecticut)
ABSTRACT An embodiment of the invention is directed to a microfabricated, silicon-based, Convection Enhanced Delivery (CED) device. The device comprises a silicon shank portion, at least one individual parylene channel disposed along at least a part of an entire length of the shank, wherein the channel has one or more dimensioned fluid exit ports disposed at one or more respective locations of the channel and a fluid (drug) input opening. The fluid input opening may be configured or adapted to be connected to a fluid reservoir and/or a pump and/or a meter and/or a valve or other suitable control device(s) or apparatus that supplies and/or delivers fluid (e.g., a drug) to the microfabricated device. The device may have multiple channels disposed side by side or in different surfaces of the device. The device may be rigid, or flexible, in which case a flexible device can be attached to a bio-degradable support scaffold that provides sufficient structural rigidity for insertion of the device into the target tissue. In certain “functionalized” embodiments of the invention, the CED device is equipped with integrated electrodes and/or a sensor (e.g., glutamate) to detect and convey selective parametric information. Another embodiment of the invention is directed to a CED method for drugs and/or other agents. The method may comprise the delivery of enzymes or other materials to modify tissue permeability and improve drug diffusion. Another embodiment of the invention is directed to a method for making a device for CED of drugs.
FILED Wednesday, June 25, 2014
APPL NO 14/314119
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/47 (20130101) Original (OR) Class

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/1408 (20130101)
A61M 37/00 (20130101)
A61M 37/0015 (20130101)
A61M 2037/003 (20130101)
A61M 2037/0023 (20130101)
A61M 2210/0693 (20130101)

Enzymes
C12Y 302/01 (20130101)
C12Y 302/01035 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844662 Leuthardt et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) WASHINGTON UNIVERSITY (St. Louis, Missouri)
INVENTOR(S) Eric C. Leuthardt (St. Louis, Missouri);  Daniel W. Moran (St. Louis, Missouri);  Matthew R. MacEwan (St. Louis, Missouri)
ABSTRACT A system for use in stimulating bone growth, tissue healing, and/or pain control is described. The system includes a screw, a battery, a controller, and means for connecting the battery such that current is routed from the battery through the screw and thence to a target area of interest requiring treatment. The screw includes an elongate shaft having a length extending between opposite ends. The shaft has an insulating coating extending along at least a portion of the length. The thickness of the insulating coating at various portions of the shaft is modulated to optimally direct current to a target area of interest requiring treatment. The controller adjusts the duty cycle of the current flow over the treatment period.
FILED Friday, March 14, 2014
APPL NO 14/212648
ART UNIT 3769 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/7037 (20130101)
A61B 17/7059 (20130101)
A61B 17/7061 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/205 (20130101)
A61N 1/326 (20130101)
A61N 1/0558 (20130101) Original (OR) Class
A61N 1/36071 (20130101)
A61N 1/36103 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09844684 Luan et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Shuang Luan (Albuquerque, New Mexico);  Daniel Andres Riofrio Almeida (Quito, Ecuador)
ABSTRACT An optimization technique for use with radiation therapy planning that combines stochastic optimization techniques such as Particle Swarm Optimization (PSO) with deterministic techniques to solve for optimal and reliable locations for delivery of radiation doses to a targeted tumor while minimizing the radiation dose experienced by the surrounding critical structures such as normal tissues and organs.
FILED Thursday, April 30, 2015
APPL NO 15/304306
ART UNIT 2884 — Optics
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/10 (20130101)
A61N 5/103 (20130101)
A61N 5/1001 (20130101)
A61N 5/1007 (20130101)
A61N 5/1031 (20130101) Original (OR) Class
A61N 5/1084 (20130101)
A61N 2005/101 (20130101)
A61N 2005/1024 (20130101)
A61N 2005/1034 (20130101)

Electric Digital Data Processing
G06F 19/325 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/006 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845245 Alcazar Jorba et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Daniel Alcazar Jorba (Remich, Luxembourg);  Edwin Lorimer Thomas (Houston, Texas)
ABSTRACT Method for making a liquid foam from graphene. The method includes preparing an aqueous dispersion of graphene oxide and adding a water miscible compound to the aqueous dispersion to produce a mixture including a modified form of graphene oxide. A second immiscible fluid (a gas or a liquid) with or without a surfactant are added to the mixture and agitated to form a fluid/water composite wherein the modified form of graphene oxide aggregates at the interfaces between the fluid and water to form either a closed or open cell foam. The modified form of graphene oxide is the foaming agent.
FILED Monday, March 23, 2015
APPL NO 14/665053
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Mixing, e.g Dissolving, Emulsifying, Dispersing
B01F 17/0042 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/043 (20130101)
C01B 31/0438 (20130101)
C01B 31/0484 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845294 Yamamoto et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The University of Toledo (Toledo, Ohio)
ASSIGNEE(S) The University of Toledo (Toledo, Ohio)
INVENTOR(S) Kana Yamamoto (Toledo, Ohio);  Sridhar Viamajala (Toledo, Ohio);  Sasidhar Varanasi (Toledo, Ohio);  Ajith Yapa Mudiyanselage (Toledo, Ohio);  Godwin Ameh Abel (Toledo, Ohio)
ABSTRACT Provided herein is a method of producing C11, C12, and C13 nylon precursors from oleic acid or esters of oleic acid, the method involving amide formation, ring-closing metathesis, and hydrogenation. Further provided are the products of the method described. Provided herein is a method for producing a lactam, the method comprising the steps of converting oleic acid or an ester of oleic acid into an amide having a general formula of H3C—(CH2)rCH═CH—(CH2)rCONR—(CH2)n-CH═CH2, wherein n is 1, 2, or 3, and R is either hydrogen or benzyl; subjecting the amide to a ring-closing metathesis reaction to produce an intermediate having a general formula of —(CH2)rCONR—(CH2) n-CH═CH2-, wherein n is 1, 2, or 3, R is either hydrogen or benzyl, and both ends are connected to each other; and hydrogenating the intermediate to produce a saturated lactam. In certain embodiments, the saturated lactam has a formula of —NH—(CH2) 10-CO—.
FILED Thursday, July 02, 2015
APPL NO 15/323583
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 225/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845317 Burke et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Martin D. Burke (Champaign, Illinois);  David M. Knapp (Boonville, Indiana);  Eric P. Gillis (Wallingford, Connecticut)
ABSTRACT A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture:
R1—B-T  (I);
where R1 represents an organic group, T represents a conformationally rigid protecting group, and B represents boron having sp3 hybridization. When unprotected, the corresponding organoboronic acid is unstable by the boronic acid neat stability test. The reaction mixture further includes a base having a pKB of at least 1 and a palladium catalyst. The method further includes forming a cross-coupled product in the reaction mixture.
FILED Friday, April 29, 2016
APPL NO 15/142418
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 61/00 (20130101)

Acyclic or Carbocyclic Compounds
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 1/321 (20130101)
C07C 13/28 (20130101)
C07C 15/46 (20130101)
C07C 15/58 (20130101)
C07C 41/30 (20130101)
C07C 41/30 (20130101)
C07C 43/2055 (20130101)
C07C 2527/173 (20130101)
C07C 2531/12 (20130101)
C07C 2531/24 (20130101)
C07C 2601/02 (20170501)

Heterocyclic Compounds
C07D 207/34 (20130101)
C07D 207/325 (20130101)
C07D 207/333 (20130101)
C07D 209/12 (20130101)
C07D 209/30 (20130101)
C07D 213/16 (20130101)
C07D 213/50 (20130101)
C07D 213/57 (20130101)
C07D 213/73 (20130101)
C07D 241/42 (20130101)
C07D 263/56 (20130101)
C07D 307/36 (20130101)
C07D 307/42 (20130101)
C07D 307/80 (20130101)
C07D 333/16 (20130101)
C07D 401/04 (20130101)
C07D 405/04 (20130101)
C07D 405/12 (20130101)
C07D 409/04 (20130101)
C07D 413/04 (20130101) Original (OR) Class

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/55 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845380 Bara et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) The Board of Trustees of the University of Alabama (Tuscaloosa, Alabama)
ASSIGNEE(S) The Board of Trustees of The University of Alabama (Tuscaloosa, Alabama)
INVENTOR(S) Jason Edward Bara (Tuscaloosa, Alabama);  Matthew S. Shannon (Northport, Alabama);  John David Roveda, Jr. (Mobile, Alabama);  David A. Wallace (Brentwood, Tennessee);  Max Simon Mittenthal (Tuscaloosa, Alabama)
ABSTRACT Disclosed are compositions and methods of preparing ionic polyimides. Also disclosed are methods to tune the properties of the ionic polyimide by designing the components of the ionic polyimide. Additionally, disclosed herein is a composition comprising an ionic polyimide. Also disclosed herein is a composition comprising an ionic polyimide and an ionic liquid. The disclosed compositions can be utilized to capture gases.
FILED Tuesday, December 29, 2015
APPL NO 14/982386
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 53/228 (20130101)
B01D 53/1475 (20130101)
B01D 53/1493 (20130101)
B01D 71/64 (20130101)
B01D 2252/30 (20130101)
B01D 2257/504 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/262 (20130101)
B01J 20/264 (20130101)
B01J 20/28033 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 73/0616 (20130101)
C08G 73/1039 (20130101)
C08G 73/1067 (20130101)
C08G 73/1085 (20130101) Original (OR) Class

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 5/3445 (20130101)
C08K 5/3445 (20130101)

Compositions of Macromolecular Compounds
C08L 79/08 (20130101)

Capture, Storage, Sequestration or Disposal of Greenhouse Gases [GHG]
Y02C 10/10 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/152 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846137 Bhansali et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) Shekhar Bhansali (Weston, Florida);  Pandiaraj Manickam (Miami, Florida)
ASSIGNEE(S) THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTESS (Miami, Florida)
INVENTOR(S) Shekhar Bhansali (Weston, Florida);  Pandiaraj Manickam (Miami, Florida)
ABSTRACT The subject invention provides materials and methods of fabricating and using an electrochemical biosensor for continuous detection of biological analytes. In a specific embodiment, the biosensor detects a given analyte when the analyte binds with a molecularly imprinted polymer (MIP) matrix immobilized atop a sensing substrate eliminating the need for a redox probing agent commonly found in electrochemical biosensors. Furthermore, the detection sensitivity of the biosensor is enhanced by modifying the electrode surface with a plurality of nanoscopic metallic structures. Advantageously, technologies provided herein can be used in a variety of low-power electronics for wearable applications.
FILED Friday, August 19, 2016
APPL NO 15/242082
ART UNIT 1759 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/3278 (20130101) Original (OR) Class
G01N 33/743 (20130101)
G01N 33/5438 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846627 Solihin et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S) North Carolina State University (Raleigh, North Carolina)
INVENTOR(S) Yan Solihin (Raleigh, North Carolina);  Yipeng Wang (Raleigh, North Carolina);  Amro Awad (Raleigh, North Carolina)
ABSTRACT Systems and methods for modeling memory access behavior and memory traffic timing behavior are disclosed. According to an aspect, a method includes receiving data indicative of memory access behavior resulting from instructions executed on a processor. The method also includes determining a statistical profile of the memory access behavior, the profile including tuple statistics of memory access behavior. Further, the method includes generating a clone of the executed instructions based on the statistical profile for use in simulating the memory access behavior.
FILED Monday, February 15, 2016
APPL NO 15/044044
ART UNIT 2135 — Memory Access and Control
CURRENT CPC
Electric Digital Data Processing
G06F 11/3037 (20130101) Original (OR) Class
G06F 11/3447 (20130101)
G06F 11/3452 (20130101)
G06F 11/3461 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846843 Howard et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Ayanna Howard (Atlanta, Georgia);  LaVonda Brown (Atlanta, Georgia);  Hae Won Park (Norcross, Georgia)
ABSTRACT Methods and systems for facilitating interactions between a robot and user are provided. The system may include a robot and an electronic device communicatively coupled to the robot. The robot may include a plurality of actuators ones of which are configured to cause a mechanical action of at least one component of the robot, a plurality of interaction inducing components operatively connected to corresponding ones of the plurality of actuators, at least one sensor configured to detect at least one action of a user, a processor, and a memory coupled to the processor, the memory including computer readable program code embodied therein that, when executed by the processor, causes the processor to: receive a task; identify, based on similarity to the task received, a similar task from a database stored in the memory, the database including at least one stored task-solution pair; execute the solution associated with the similar task; and store a new task-solution pair responsive to the robot performing a solution relating to the task.
FILED Monday, October 27, 2014
APPL NO 14/524405
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 11/003 (20130101)
B25J 11/0005 (20130101)

Computer Systems Based on Specific Computational Models
G06N 5/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847125 Friedman et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) Eby Friedman (Rochester, New York);  Isaac Richter (East Amherst, New York);  Xiaochen Guo (Bethlehem, Pennsylvania);  Mohammad Kazemi (Rochester, New York);  Kamil Pas (Ridgewood, New York);  Ravi Patel (Victor, New York);  Engin Ipek (Pittsford, New York);  Ji Liu (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Eby Friedman (Rochester, New York);  Isaac Richter (East Amherst, New York);  Xiaochen Guo (Bethlehem, Pennsylvania);  Mohammad Kazemi (Rochester, New York);  Kamil Pas (Ridgewood, New York);  Ravi Patel (Victor, New York);  Engin Ipek (Pittsford, New York);  Ji Liu (Rochester, New York)
ABSTRACT Presented is a method and apparatus for solving. The method includes receiving, by a resistive memory array, a first data, the resistive memory array comprising a plurality of cells, wherein the receiving comprises setting a plurality of resistances on the plurality of cells, wherein each of the plurality of resistances are based on the first data. The method further includes receiving, by the resistive memory array, a second data, wherein the receiving comprises applying at least one of a current and a voltage based on the second data on the plurality of cells. The method still further includes determining, by the resistive memory array, an initial unknown value, the initial value based on the first data and the second data.
FILED Friday, August 05, 2016
APPL NO 15/229818
ART UNIT 2827 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 7/16 (20130101)
G11C 13/0002 (20130101)
G11C 13/004 (20130101) Original (OR) Class
G11C 13/0069 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847570 Georgakopoulos et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Office of Emerging Frontiers in Research and Innovation (EFRI)
APPLICANT(S) Florida International University Board of Trustees (Miami, Florida)
ASSIGNEE(S) The Florida International University Board of Trustees (Miami, Florida)
INVENTOR(S) Stavros Georgakopoulos (Boca Raton, Florida);  Shun Yao (Miami, Florida)
ABSTRACT Novel and advantageous antennas are provided. A multi-functional antenna can morph in order to change geometrical shape and thereby change its antenna radiation characteristics. Such characteristics can include radiation pattern, bandwidth, beamwidth, operational frequency, and directivity. The antenna can therefore be multifunctional such that one single antenna can serve multiple applications.
FILED Monday, July 20, 2015
APPL NO 14/803376
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/08 (20130101)
H01Q 1/36 (20130101) Original (OR) Class
H01Q 9/16 (20130101)
H01Q 9/18 (20130101)
H01Q 9/20 (20130101)
H01Q 11/08 (20130101)
H01Q 11/083 (20130101)
H01Q 11/086 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 09845269 Kang et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) National Institute of Aerospace Associates (Hampton, Virginia);  The United States of America, as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) National Institute of Aerospace Associates (Hampton, Virginia);  The United States of America as represented by the Administration of NASA (Washington, District of Columbia)
INVENTOR(S) Jin Ho Kang (Newport News, Virginia);  Robert G. Bryant (Lightfoot, Virginia);  Cheol Park (Yorktown, Virginia);  Godfrey Sauti (Hampton, Virginia);  Luke Gibbons (Williamsburg, Virginia);  Sharon Lowther (Hampton, Virginia);  Sheila A. Thibeault (Hampton, Virginia);  Catharine C. Fay (Yorktown, Virginia)
ABSTRACT Multifunctional Boron Nitride nanotube-Boron Nitride (BN—BN) nanocomposites for energy transducers, thermal conductors, anti-penetrator/wear resistance coatings, and radiation hardened materials for harsh environments. An all boron-nitride structured BN—BN composite is synthesized. A boron nitride containing precursor is synthesized, then mixed with boron nitride nanotubes (BNNTs) to produce a composite solution which is used to make green bodies of different forms including, for example, fibers, mats, films, and plates. The green bodies are pyrolized to facilitate transformation into BN—BN composite ceramics. The pyrolysis temperature, pressure, atmosphere and time are controlled to produce a desired BN crystalline structure. The wholly BN structured materials exhibit excellent thermal stability, high thermal conductivity, piezoelectricity as well as enhanced toughness, hardness, and radiation shielding properties. By substituting with other elements into the original structure of the nanotubes and/or matrix, new nanocomposites (i.e., BCN, BCSiN ceramics) which possess excellent hardness, tailored photonic bandgap and photoluminescence, result.
FILED Friday, March 29, 2013
APPL NO 13/986089
ART UNIT 1741 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/583 (20130101) Original (OR) Class
C04B 35/806 (20130101)
C04B 35/6229 (20130101)
C04B 2235/46 (20130101)
C04B 2235/94 (20130101)
C04B 2235/386 (20130101)
C04B 2235/422 (20130101)
C04B 2235/428 (20130101)
C04B 2235/465 (20130101)
C04B 2235/486 (20130101)
C04B 2235/3821 (20130101)
C04B 2235/3826 (20130101)
C04B 2235/5256 (20130101)
C04B 2235/5284 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 41/43 (20130101)
H01L 41/187 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845898 Johnson et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as Represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Administrator of NASA (Washington, District of Columbia)
INVENTOR(S) Wesley L. Johnson (Middleburg Heights, Ohio);  Charles R. Cook (Gainesville, Florida)
ABSTRACT A pressure relief valve includes a housing having a fluid inlet and at least one fluid outlet. A first structure mounted in the housing and fixed in relation thereto is in magnetic attraction with a second structure coupled to a piston disposed in a portion of the housing. The piston defines a chamber disposed adjacent to the fluid outlet(s) throughout the piston's stroke. The piston includes a sealing element providing a sealing force to prevent flow through the valve. The sealing force is independent of the magnetic attraction force between the first and second structures.
FILED Wednesday, September 30, 2015
APPL NO 14/871127
ART UNIT 3753 — Fluid Handling and Dispensing
CURRENT CPC
Valves; Taps; Cocks; Actuating-floats; Devices for Venting or Aerating
F16K 11/06 (20130101)
F16K 17/02 (20130101)
F16K 27/04 (20130101)
F16K 31/084 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846023 Soloway
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as Represented by the Administrator of the National Aeronautics and Space Administration (NASA) (Washington, District of Columbia)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA (Washington, District of Columbia)
INVENTOR(S) Donald I. Soloway (San Jose, California)
ABSTRACT A method for monitoring position of and controlling a second nanosatellite (NS) relative to a position of a first NS. Each of the first and second NSs has a rectangular or cubical configuration of independently activatable, current-carrying solenoids, each solenoid having an independent magnetic dipole moment vector, μ1 and μ2. A vector force F and a vector torque are expressed as linear or bilinear combinations of the first set and second set of magnetic moments, and a distance vector extending between the first and second NSs is estimated. Control equations are applied to estimate vectors, μ1 and μ2, required to move the NSs toward a desired NS configuration. This extends to control of N nanosatellites.
FILED Tuesday, July 01, 2014
APPL NO 14/321447
ART UNIT 2865 — Printing/Measuring and Testing
CURRENT CPC
Cosmonautics; Vehicles or Equipment Therefor
B64G 1/24 (20130101)
B64G 1/366 (20130101)
B64G 1/1085 (20130101)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 7/003 (20130101) Original (OR) Class
G01B 7/30 (20130101)

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 5/0247 (20130101)
G01S 5/0284 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09846079 Stephen et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
INVENTOR(S) Mark A. Stephen (Catonsville, Maryland);  Molly E. Fahey (Washington, District of Columbia);  Michael A. Krainak (Fulton, Maryland)
ABSTRACT Systems, methods, and devices may provide an optical scheme that achieves simultaneous wavelength channels and maintains the resolution and luminosity of an etalon. Various embodiments may provide a method to optically recirculate the light reflected from the etalon back through the same etalon at new angles. Various embodiments create an etalon spectrometer based on angular dispersion without moving parts and without losing the light that is not initially transmitted. Various embodiments may provide a spectrally-resolved receiver and/or transmitter. Various embodiments may provide a system including a retro-reflector, a detector or transmitter array, and an etalon disposed between the retro-reflector and the detector or transmitter array, wherein the retro-reflector is configured to redirect light reflected by the etalon back to the etalon at a different angle of incidence than an original angle of incidence on the etalon of the light reflected by the etalon.
FILED Thursday, June 23, 2016
APPL NO 15/190727
ART UNIT 2877 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/26 (20130101)
G01J 3/45 (20130101) Original (OR) Class

Optical Elements, Systems, or Apparatus
G02B 5/122 (20130101)
G02B 5/284 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09848485 Corke et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) UNIVERSITY OF NOTRE DAME DU LAC (Notre Dame, Indiana);  Creare LLC (Hanover, New Hampshire)
ASSIGNEE(S) University of Notre Dame du Lac (South Bend, Indiana);  Creare LLC (Hanover, New Hampshire)
INVENTOR(S) Thomas C. Corke (South Bend, Indiana);  Richard Kaszeta (Hanover, New Hampshire);  Calman Gold (Hanover, New Hampshire)
ABSTRACT A plasma generating device intended to induce a flow in a fluid via plasma generation includes a dielectric separating two electrodes and a power supply. The first electrode is exposed to a fluid flow while the second electrode is positioned under the dielectric. The power supply is electrically coupled to a switch and the first and second electrodes. When the power supply is energized by repeated action of the switch, it causes a pulsed DC current between the electrodes which causes the fluid to ionize generating a plasma. The generation of the plasma induces a force with a velocity component in the fluid.
FILED Friday, December 09, 2016
APPL NO 15/374707
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Plasma Technique; Production of Accelerated Electrically-charged Particles or of Neutrons; Production or Acceleration of Neutral Molecular or Atomic Beams
H05H 1/24 (20130101)
H05H 1/2406 (20130101) Original (OR) Class
H05H 2001/2412 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 09844662 Leuthardt et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) WASHINGTON UNIVERSITY (St. Louis, Missouri)
INVENTOR(S) Eric C. Leuthardt (St. Louis, Missouri);  Daniel W. Moran (St. Louis, Missouri);  Matthew R. MacEwan (St. Louis, Missouri)
ABSTRACT A system for use in stimulating bone growth, tissue healing, and/or pain control is described. The system includes a screw, a battery, a controller, and means for connecting the battery such that current is routed from the battery through the screw and thence to a target area of interest requiring treatment. The screw includes an elongate shaft having a length extending between opposite ends. The shaft has an insulating coating extending along at least a portion of the length. The thickness of the insulating coating at various portions of the shaft is modulated to optimally direct current to a target area of interest requiring treatment. The controller adjusts the duty cycle of the current flow over the treatment period.
FILED Friday, March 14, 2014
APPL NO 14/212648
ART UNIT 3769 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/7037 (20130101)
A61B 17/7059 (20130101)
A61B 17/7061 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/205 (20130101)
A61N 1/326 (20130101)
A61N 1/0558 (20130101) Original (OR) Class
A61N 1/36071 (20130101)
A61N 1/36103 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845499 Hung et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Combinati Incorporated (Palo Alto, California)
ASSIGNEE(S) COMBINATI INCORPORATED (Palo Alto, California)
INVENTOR(S) Ju-Sung Hung (Palo Alto, California);  Andrew Zayac (San Leandro, California);  Megan Dueck (San Diego, California)
ABSTRACT A microfluidic device can have a plurality of microchambers connected to a microchannel via siphon apertures. The microfluidic device may be formed from a thermoplastic and capped by a thermoplastic thin film. The microfluidic device may be used for digital polymerase chain reactions by forcing reagent into the microchambers at low pressure via an inlet, forcing any gas trapped in the microfluidic device to outgas through the thin film by applying high pressure to the microfluidic device via inlets and outlets of the microfluidic device, and applying air at low pressure to the inlets in order to digitize the chambers such that the reagent in each chamber is isolated from the reagent in other chambers by an air gap. After digitization, the device may be used to run a digital polymerase chain reaction process.
FILED Tuesday, November 29, 2016
APPL NO 15/363896
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50273 (20130101)
B01L 3/502707 (20130101)
B01L 3/502715 (20130101)
B01L 2200/12 (20130101)
B01L 2300/12 (20130101)
B01L 2300/041 (20130101)
B01L 2300/0832 (20130101)
B01L 2300/0864 (20130101)
B01L 2400/0487 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09848485 Corke et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) UNIVERSITY OF NOTRE DAME DU LAC (Notre Dame, Indiana);  Creare LLC (Hanover, New Hampshire)
ASSIGNEE(S) University of Notre Dame du Lac (South Bend, Indiana);  Creare LLC (Hanover, New Hampshire)
INVENTOR(S) Thomas C. Corke (South Bend, Indiana);  Richard Kaszeta (Hanover, New Hampshire);  Calman Gold (Hanover, New Hampshire)
ABSTRACT A plasma generating device intended to induce a flow in a fluid via plasma generation includes a dielectric separating two electrodes and a power supply. The first electrode is exposed to a fluid flow while the second electrode is positioned under the dielectric. The power supply is electrically coupled to a switch and the first and second electrodes. When the power supply is energized by repeated action of the switch, it causes a pulsed DC current between the electrodes which causes the fluid to ionize generating a plasma. The generation of the plasma induces a force with a velocity component in the fluid.
FILED Friday, December 09, 2016
APPL NO 15/374707
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Plasma Technique; Production of Accelerated Electrically-charged Particles or of Neutrons; Production or Acceleration of Neutral Molecular or Atomic Beams
H05H 1/24 (20130101)
H05H 1/2406 (20130101) Original (OR) Class
H05H 2001/2412 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 09844509 Dewitt
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) PFIZER INC. (New York, New York)
ASSIGNEE(S) PFIZER INC. (New York, New York)
INVENTOR(S) David M. Dewitt (Allston, Massachusetts)
ABSTRACT This application provides a high throughput method of making nanoparticles that utilizes plates comprising wells (e.g., 96-well plates).
FILED Monday, June 06, 2016
APPL NO 15/173752
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Containers Specially Adapted for Medical or Pharmaceutical Purposes; Devices or Methods Specially Adapted for Bringing Pharmaceutical Products into Particular Physical or Administering Forms; Devices for Administering Food or Medicines Orally; Baby Comforters; Devices for Receiving Spittle
A61J 3/00 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1682 (20130101) Original (OR) Class
A61K 9/5123 (20130101)
A61K 9/5146 (20130101)
A61K 9/5153 (20130101)
A61K 9/5192 (20130101)
A61K 31/337 (20130101)
A61K 47/48969 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/773 (20130101)
Y10S 977/906 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09845554 Zhang et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Advanced Technology Program (NIST-ATP)
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Mei Zhang (Tallahassee, Florida);  Shaoli Fang (Richardson, Texas);  Ray H. Baughman (Dallas, Texas);  Anvar A. Zakhidov (McKinney, Texas);  Ali E. Aliev (Dallas, Texas);  Sergey Li (Dallas, Texas);  Chris Williams (Dallas, Texas)
ABSTRACT The present invention is directed to nanofiber yarns, ribbons, and sheets; to methods of making said yarns, ribbons, and sheets; and to applications of said yarns, ribbons, and sheets. In some embodiments, the nanotube yarns, ribbons, and sheets comprise carbon nanotubes. Particularly, such carbon nanotube yarns of the present invention provide unique properties and property combinations such as extreme toughness, resistance to failure at knots, high electrical and thermal conductivities, high absorption of energy that occurs reversibly, up to 13% strain-to-failure compared with the few percent strain-to-failure of other fibers with similar toughness, very high resistance to creep, retention of strength even when heated in air at 450° C. for one hour, and very high radiation and UV resistance, even when irradiated in air. Furthermore these nanotube yarns can be spun as one micron diameter yarns and plied at will to make two-fold, four-fold, and higher fold yarns. Additional embodiments provide for the spinning of nanofiber sheets having arbitrarily large widths. In still additional embodiments, the present invention is directed to applications and devices that utilize and/or comprise the nanofiber yarns, ribbons, and sheets of the present invention.
FILED Friday, February 26, 2016
APPL NO 15/055395
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 5/02 (20130101)
B32B 5/12 (20130101)
B32B 37/12 (20130101)
B32B 2262/106 (20130101)
B32B 2307/202 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/0293 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/50 (20130101)

Chemical Features in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons; Apparatus Specially Adapted for the Manufacture of Carbon Filaments
D01F 9/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 09846277 Hu et al.
FUNDED BY
National Security Agency (NSA)
Maryland Procurement Office (MPO)
APPLICANT(S) HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (Houston, Texas)
ASSIGNEE(S) Hewlett Packard Enterprise Development LP (Houston, Texas)
INVENTOR(S) Yingtao Hu (Palo Alto, California);  Di Liang (Santa Barbara, California);  Raymond G Beausoleil (Seattle, Washington)
ABSTRACT Examples herein relate to semiconductor devices having contacts that provide low contact resistance for both p-type and n-type materials. An example semiconductor device includes a semiconductor device layer having at least one of a p-type material or a n-type material. A contact is manufactured on the semiconductor device layer with a complementary metal-oxide-semiconductor process. The contact includes a first layer having palladium coupled with a surface of the semiconductor device layer, a conducting second layer coupled with the first layer, and a third layer having germanium coupled with the second conducting layer.
FILED Thursday, July 28, 2016
APPL NO 15/222922
ART UNIT 2874 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/122 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09847121 Frank
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) David J. Frank (Yorktown Heights, New York)
ABSTRACT A quantum mechanical radio frequency (RF) signaling system includes a transmission line that receives and conducts an RF pulse signal operating at a radio frequency, a first qubit having a quantum mechanical state that is a linear combination of at least two quantum mechanical eigenstates, and a first network of reactive electrical components having an input that is coupled to the transmission line for receiving the RF pulse signal and an output that is coupled to the first qubit. The first network of reactive electrical components attenuates the amplitude of the RF pulse signal and produces a first attenuated RF pulse signal that is applied to the first qubit. The first attenuated RF pulse signal operates at the radio frequency and has a first attenuated amplitude that causes a predefined change in the linear combination of at least two quantum mechanical eigenstates within the first qubit.
FILED Sunday, September 13, 2015
APPL NO 14/852614
ART UNIT 2631 — Digital Communications
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 99/002 (20130101)

Static Stores
G11C 11/44 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 09846596 Nogin et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL Laboratories, LLC (Malibu, California)
INVENTOR(S) Aleksey Nogin (Fresno, California);  Kirill Minkovich (Campbell, California);  Karim El Defrawy (Santa Monica, California);  Joshua W. Baron (Los Angeles, California);  Eric P. Tressler (Oakland, Maryland);  Gavin D. Holland (Oak Park, California)
ABSTRACT Described is a system for a cloud control operations plane. In operation, a job is broadcast to a plurality of physical hosts, one or more of the physical hosts having a control operations plane (COP) node and a service node associated with the COP node. The COP nodes jointly create a private job assignment. A set of job assignments is redundantly distributed to individual COP nodes pursuant to the private job assignments, such that each individual COP node is only aware of its own assignment and corresponding job. The service nodes then each complete a task associated with the job and generate an output. When a set of service nodes performing a redundant job complete their task, the corresponding COP nodes jointly perform a private result checking protocol to generate a final output. The final output is then sent to the user.
FILED Tuesday, June 24, 2014
APPL NO 14/313543
ART UNIT 2437 — Cryptography and Security
CURRENT CPC
Electric Digital Data Processing
G06F 9/4881 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Transportation (USDOT) 

US D805416 Rymer et al.
FUNDED BY
Department of Transportation (USDOT)
U.S. State Government
State of California
California Department of Transportation (CALTRANS)
APPLICANT(S) State of California, Department of Transportation (Sacramento, California)
ASSIGNEE(S)
INVENTOR(S) Bruce C. Rymer (Sacramento, California);  Paul R. Donavan (Petaluma, California)
ABSTRACT
FILED Thursday, November 05, 2015
APPL NO 29/544678
ART UNIT 2913 — Design
CURRENT CPC
Measuring, testing, or signalling instruments
D10/113.100
VIEW PATENT @ USPTO:  Full Text   PDF 

Non-Profit Organization (NPO) 

US 09845554 Zhang et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Advanced Technology Program (NIST-ATP)
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Non-Profit Organization (NPO)
Robert A. Welch Foundation
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Mei Zhang (Tallahassee, Florida);  Shaoli Fang (Richardson, Texas);  Ray H. Baughman (Dallas, Texas);  Anvar A. Zakhidov (McKinney, Texas);  Ali E. Aliev (Dallas, Texas);  Sergey Li (Dallas, Texas);  Chris Williams (Dallas, Texas)
ABSTRACT The present invention is directed to nanofiber yarns, ribbons, and sheets; to methods of making said yarns, ribbons, and sheets; and to applications of said yarns, ribbons, and sheets. In some embodiments, the nanotube yarns, ribbons, and sheets comprise carbon nanotubes. Particularly, such carbon nanotube yarns of the present invention provide unique properties and property combinations such as extreme toughness, resistance to failure at knots, high electrical and thermal conductivities, high absorption of energy that occurs reversibly, up to 13% strain-to-failure compared with the few percent strain-to-failure of other fibers with similar toughness, very high resistance to creep, retention of strength even when heated in air at 450° C. for one hour, and very high radiation and UV resistance, even when irradiated in air. Furthermore these nanotube yarns can be spun as one micron diameter yarns and plied at will to make two-fold, four-fold, and higher fold yarns. Additional embodiments provide for the spinning of nanofiber sheets having arbitrarily large widths. In still additional embodiments, the present invention is directed to applications and devices that utilize and/or comprise the nanofiber yarns, ribbons, and sheets of the present invention.
FILED Friday, February 26, 2016
APPL NO 15/055395
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 5/02 (20130101)
B32B 5/12 (20130101)
B32B 37/12 (20130101)
B32B 2262/106 (20130101)
B32B 2307/202 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 31/0293 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/50 (20130101)

Chemical Features in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons; Apparatus Specially Adapted for the Manufacture of Carbon Filaments
D01F 9/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US D805416 Rymer et al.
FUNDED BY
Department of Transportation (USDOT)
U.S. State Government
State of California
California Department of Transportation (CALTRANS)
APPLICANT(S) State of California, Department of Transportation (Sacramento, California)
ASSIGNEE(S)
INVENTOR(S) Bruce C. Rymer (Sacramento, California);  Paul R. Donavan (Petaluma, California)
ABSTRACT
FILED Thursday, November 05, 2015
APPL NO 29/544678
ART UNIT 2913 — Design
CURRENT CPC
Measuring, testing, or signalling instruments
D10/113.100
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 09846736 Song
FUNDED BY
APPLICANT(S) Ha Yoon Song (Seoul, South Korea)
ASSIGNEE(S) SANGSU-DONG, HONGIK UNIVERSITY (Seoul, South Korea);  HONGIK UNIVERSITY INDUSTRY-ACADEMIA COOPERATION FOUNDATION (Seoul, South Korea)
INVENTOR(S) Ha Yoon Song (Seoul, South Korea)
ABSTRACT Disclosed is a method of predicting user's position. This method comprises, creating information on a plurality of location clusters by processing a plurality of position data for a user with a probability based clustering algorithm; receiving a current position data of the user and determining a first location cluster to which the current data is mapped among the plurality of location clusters; and creating second information related to a probability that the user moves from the first location cluster to a second location cluster among the plurality of location clusters. The position data is a data tuple including latitude, longitude, and time. For all the plurality of location clusters, the information includes a determined representative position value of each of the location clusters.
FILED Monday, June 25, 2012
APPL NO 14/369585
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Electric Digital Data Processing
G06F 17/30598 (20130101) Original (OR) Class

Computer Systems Based on Specific Computational Models
G06N 99/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, December 19, 2017.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2017/fedinvent-patents-20171219.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital